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Abstract
Penile circumcision reduces HIV susceptibility by up to 60% in men; however, many
men prefer to remain uncircumcised for personal or cultural reasons. Penile circumcision
protects against HIV by reducing anaerobic bacteria on the penis. Penile anaerobes cause
local inflammation and the recruitment of HIV-susceptible CD4+CCR5+ cells, increasing the
likelihood that exposure to HIV during intercourse results in infection. To determine if a nonsurgical intervention can reduce penile anaerobes and HIV target cells, we randomized men
to antimicrobial treatment prior to circumcision. To be able to quantify the effect of
antimicrobials, we developed a novel deep-learning algorithm to quantify HIV target cells in
immunofluorescent microscopy images of foreskin. We found that men who received
antimicrobials had a lower density of HIV target cells, which correlated with reductions in
penile anaerobes and secreted inflammatory mediators. These results suggest that
microbiome-based interventions could be a potential tool for HIV prevention.

Keywords
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Summary for Lay Audience
Male circumcision has been shown to be able to reduce the risk of acquiring HIV by
up to 60% in men. Despite these benefits, many at-risk men still choose to not undergo this
procedure and it is not completely understood how circumcision can have a protective effect
against HIV infection. One way that circumcision protects against HIV is by eliminating
specific species of anaerobic bacteria that have been shown to recruit HIV-susceptible cells
in the penis. To determine if a non-surgical intervention could similarly eliminate anaerobes
from the penis, we completed a clinical trial testing the effect of commonly available
antibacterial agents on penile bacteria and the abundance of HIV-susceptible cells in penile
tissue. To accomplish this, we developed a machine learning program to automatically
analyze and quantify HIV target cells in microscopy images generated from tissues collected
after the course of antimicrobials. We found that antibiotic treatments reduced penile
bacteria, inflammation, and abundance of HIV-susceptible cells. The results from this study
shown that antibiotic treatment could be used as a potential tool for HIV prevention.
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Chapter 1

1

Introduction

1.1 HIV prevention strategies
Over the past 4 decades, considerable progress has made in implementing HIV
prevention strategies and improving the life expectancy of HIV infected individuals (1,2).
While there is currently no cure for HIV, providing early and effective antiretroviral
therapy (ART) for individuals infected with HIV significantly reduces the risk of further
transmission to their partner and allows infected individuals to live long healthy lives.
Furthermore, consistent use of antiretroviral drugs as prophylaxis (PrEP) by uninfected
individuals can reduce their risk of acquiring HIV by up to 95% (3,4). However, despite
the wide range of effective HIV prevention strategies that are available, according to
estimates from UNAIDS, over 670,000 people acquired HIV in 2020 alone (5). HIV
continues to be a major public health issue. While there has been a large scale-up of HIV
treatment, the current rate of ART and PrEP provision is still outstripped by the global
rate of new infections occurring each year (6,7). The effectiveness of current treatments
in key populations is further threatened by the lack of political will to invest in and
systematically implement HIV prevention programs in endemic countries and the
emergence of antiretroviral drug resistance in eastern and southern Africa (8–11). The
development of new strategies and continued adoption of other effective prevention tools
tailored to reach key populations is essential for achieving steep reductions in new HIV
infections (2,12,13).

1.2 Voluntary penile circumcision for HIV prevention
Voluntary penile circumcision (PC) has been recommended by UNAIDS and the
WHO since 2007 as a part of a broader strategy for reducing new HIV infections in men.
As demonstrated through three large randomized controlled trials, PC decreases HIV
susceptibility in men by at least 60%. Safe PC remains the only one-time HIV prevention
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method to date (14–16). PC campaigns are actively implemented in 15 priority countries
in sub-Saharan Africa with high HIV prevalence and low PC rates (17,18). In addition to
reducing HIV risk, PC has also been found to reduce acquisition of classical sexually
transmitted infections (STI), such as herpes simplex virus type 2 (HSV-2) and high-risk
strains of human papillomavirus (HR-HPV), and to reduce the prevalence of genital
ulcerations among men (14–16,19–21). Asymptomatic HSV-2 infection is associated
with a three-fold increase in HIV acquisition and the presence of genital ulcers is
associated with an five-fold increase in HIV acquisition (22–24). PC is also associated
with reduced acquisition of HR-HPV, BV, trichomoniasis, and genital ulcerations in the
female partners of heterosexual men (25–27). Despite the benefits of PC, many eligible
men still choose to not undergo this surgical procedure and PC programs are falling well
short of their targets (1,5,18). The foreskin has previously been shown to be the main site
of HIV acquisition in heterosexual men during sexual transmission (28–32). Due to the
important role that the foreskin plays in HIV acquisition and the incomplete uptake of PC
among at-risk men, it is important to develop new non-surgical prevention tools that can
be offered to at risk men who choose to remain uncircumcised.

1.3 Immunopathogenesis of HIV in the foreskin
Sexual transmission of HIV occurs across the anogenital mucosa (penile, cervical,
vaginal, rectal) exclusively through HIV strains that use CCR5 and CD4 as receptors for
entry (33,34). In most cases of sexual HIV transmission, initial infection is typically
acquired from a single virus genotype despite the diversity of HIV genotypes found in an
infected partner’s genital secretions (35,36). Sexual transmission of HIV is surprisingly
inefficient (HIV is only transmitted in ~1/100 of penile-vaginal sex acts where the female
partner is viremic) (24,37). A wide variety of factors contributes to risk of HIV
transmission. Among these factors, the availability of CCR5+/CD4+ target cells in the atrisk partner’s genital mucosa is a critical determinant of an individual’s risk for HIV
infection (38). A variety of immune cells present in the mucosa express these two
receptors. Two dendritic cell subsets (epidermal Langerhans’ cells and dermal DCSIGN+ dendritic cells) can express CD4 and CCR5 and are abundant in the mucosa.
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While human dendritic cells are resistant to productive infection with HIV-1, they can
efficiently transmit intact, infectious virus particles to CD4+/CCR5+ T cells through a
process called trans-infection (39,40). Among the two dendritic cell subsets, Langerhans’
cells are especially important due to the proximity of these cells to the mucosal surface
(39,41). In addition to dendritic cells, CCR5+/CD4+ T cells are critical to establishing
HIV infection, and HIV pathogenesis and AIDS is caused by the progressive depletion of
CD4 T cells systemically (42). Mucosal CD4 T cells subsets, including Th17 cells, Th1
cells, and CD4 T cell subsets that express the integrins α4β7 or α4β1, have been shown to
be more susceptible to HIV infection than other CD4 T cell subsets (43–49). In animal
models, in vivo HIV susceptibility has been associated with the number of mucosal
CCR5+ CD4 T cells and/or α4β7+ CD4 T cells (50,51). Previous work by our group has
shown that men who remain seronegative despite regular unprotected sex with a viremic
partner have reduced abundance of Th17 and activated CD4 T cells in their foreskin
tissue (52). This suggests that the availability of specific highly susceptible HIV target
cells is a key determinant of HIV susceptibility.

1.4 Mucosal inflammation is critical to acquiring HIV
In the absence of inflammation, dendritic cells are generally much more abundant
than CD4 T cells in the genital mucosa. However, when the genital mucosa is inflamed,
CCR5+ CD4 T cells are recruited into the mucosa, providing additional target cells for
HIV that results in a state of increased HIV susceptibility. HIV preferentially infects and
replicates in activated CD4 T cells and so inflammation may facilitate the establishment
of productive mucosal infection by increasing both the density and the permissiveness of
mucosal CD4 T cells available for infection (36,53–57). Additionally, local immune
activation in the genital mucosa can also promote the maturation of dendritic cells, and
dendritic cells that have been exposed to bacterial antigens are more proficient at
facilitating trans-infection (39,58,59). All together, these findings emphasize the
importance of the inflammatory state of the genital mucosa in the early stages of HIV
acquisition. Bacterial STIs are strongly related to the transmission and acquisition of HIV
infection. In women, vaginal levels of pro-inflammatory cytokines/chemokines IL-1β, IL-
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8 and RANTES, as well as innate immune factors such as α-defensins, LL-37 and
lactoferrin which have pro-inflammatory properties, has been correlated with increased
density of HIV target cells in the genital mucosa and HIV acquisition (60–63). In men,
increase in penile levels of chemotactic cytokine IL-8 and MIG are directly associated
with increased risk of HIV acquisition. Penile levels of IL-8 are correlated with the tissue
density of CCR5+CD4 T cells and highly HIV-susceptible CD4 T cell subsets such
including Th17 cells (64). Increased levels of antimicrobial peptides including αdefensins and secretory leukocyte protease inhibitor (SLPI), which are normally
associated with innate immune response to bacterial pathogens, are also associated with
HIV seroconversion (65).

1.5 Penile anaerobes are associated with HIV
seroconversion, inflammation, and immune cells
Epidemiologic data suggest a link between genital anaerobes and HIV risk.
Bacterial vaginosis (BV), which is characterized by the overgrowth of facultative and
anaerobic bacteria in the vagina, has consistently been linked to increased HIV
susceptibility in women and also to increased risk of transmission of HIV from HIVpositive females to their male partners (66–68). Bacterial vaginosis is a highly prevalent
condition which affects almost one-third of women in the United States and even more
women in sub-Saharan African countries (69,70). In most women, a healthy vaginal
microbiome consists of predominantly of lactobacilli. Previous studies have shown that in
sub-Saharan African women, whose vaginal microbiome were not dominated by
lactobacilli, were 2-3 times more likely to acquire HIV after accounting for other HIV
risk factors (66,71,72). The dysbiosis of the vaginal microbiome in BV is thought to
contribute to HIV susceptibility by inducing the production of pro-inflammatory
cytokines in the vaginal mucosa and disrupting normal mucosal barrier function. While
information about the association between penile microbiome and HIV risk is limited,
recent studies by our group show the anaerobes associated with BV and HIV risk in
women can be found on the penis and suggest transmission between heterosexual couples
(73,74). In men, absolute abundance of BV-associated anaerobes (e.g., Prevotella,
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Prophyromonas, Dialister) on the penis has been associated with IL-8 levels in the subpreputial space and density of HIV susceptible CD4+ T cell subsets, such as Th17 cells,
in the foreskin (64). In a case-control study of uncircumcised men who acquired HIV
during a randomized-controlled trial of male circumcision in Uganda, the absolute
abundances of penile anaerobes at enrollment were associated with risk of acquiring HIV
during the 2-year follow-up period of the trial. Every 10-fold increase in anaerobes, such
as Prevotella, Dialister, Finegoldia, and Peptoniphilus, was associated with an increased
odds of HIV acquisition of 54 to 63%, after controlling for other known HIV risk factors.
Many of the anaerobes found to be associated with HIV seroconversion in the
uncircumcised men were also associated with BV and HIV risk in women (73,74).
However, anaerobes are highly co-occurrent in the penile microbiome, and therefore it is
difficult to infer which species are causal of HIV risk. To address this, our group also
assessed which species were associated with an increased density of HIV target cells, and
identified six species, which we named “bacteria associated with HIV seroconversion,
inflammation, and immune cells” (BASIC) (75). The reduction of these six species
(Peptostreptococcus anaerobius, Prevotella bivia, Prevotella disiens, Dialister
propionicifaciens, Dialister micraerophilus, and a genetic near neighbour of Dialister
succinatiphilus) using a microbiome-based non-surgical intervention could be a potential
HIV prevention strategy for men in endemic areas who choose to remain uncircumcised.

1.6 Proving the role of the foreskin microbiome in HIV
susceptibility
Voluntary male circumcision has been shown to be able to significantly alter the
composition of the penile microbiome, including substantially reducing the abundance of
BASIC species, suggesting that PC may reduce susceptibility to HIV by reducing penile
anaerobes, which in turn reduces local inflammation and the abundance of HIV target
cells in the foreskin (38,73,75,76). As an alternative to PC, elimination BASIC anaerobes
using topical or oral antimicrobial therapies may reduce local foreskin tissue
inflammation and the recruitment of HIV target cells. Thus, modification of the penile
microbiome could constitute a new, non-surgical method for HIV prevention for men at
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risk of HIV (31,75). However, it is not known which antimicrobial agents can eliminate
BASIC species and whether this change will result in a reduction of foreskin
inflammation and HIV susceptibility. We hypothesize that oral and/or topical
antimicrobials will reduce the abundance of BASIC species and the density of HIVsusceptible CCR5+CD4+ cells in the foreskin. To test this hypothesis, we used samples
collected during a randomized clinical trial (RCT) of licensed antibacterial agents, where
the intervention was administered for three weeks preceding PC (77). HIV-negative
Ugandan men (n=125) requesting voluntary PC were randomized to receive either no
intervention (controls) or a treatment course with one of four commonly available
antibacterial agents prior to elective PC. The density of HIV susceptible CCR5+CD4+
cells in excised foreskin collected from the RCT was then quantified, using
immunofluorescent (IF) microscopy and a novel automated deep-learning IF image
analysis algorithm, to determine the effect of antimicrobial treatments on foreskin
abundance of HIV-susceptible CCR5+ CD4+ cells. In this thesis project, I have three
objectives.

1.7 Objectives
1. Objective 1: Develop, validate, and apply automated deep-learning IF
microscopy image analysis algorithms to measure HIV target cell density in
whole foreskin tissue sections.
o Hypothesis: The automated deep-learning algorithm will be able to
segment HIV target cells with accuracy comparable to manual
identification and better than the automated pixel-based cell segmentation
workflow in the image processing software, ImageJ.
2. Objective 2: Determine the effect of antimicrobial treatments on HIV target cell
density.
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o Hypothesis: HIV target cell density will be lower in the inner foreskin of
men in the treatment groups when compared to the men in the control
group.
3. Objective 3: Determine if the relationship between antimicrobial treatments and
HIV target cell density is mediated by changes in the penile microbiome.
o Hypothesis: HIV target cell density in the inner foreskin will be
associated with the abundance of BASIC species at the time of PC (i.e.,
post-treatment, in participants randomized to the treatment arms).
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Chapter 2

2

Randomized Clinical Trial Methods

*NB* None of the methods described in Chapter 2 were performed by the candidate (Z
Shao). They are provided here for background on RCT design and sample collection.

2.1 Study Overview
This study is based on a randomized, open-label clinical trial examining the effect
of antimicrobials on HIV susceptibility in Ugandan men (77). HIV-uninfected men
(n=125) seeking voluntary PC were randomly assigned to one of five treatment arms
(n=25). Men in the control group were circumcised without delay while men in the other
4 intervention groups were asked to use either oral tinidazole, penile topical
metronidazole, penile topical clindamycin, or penile topical hydrogen peroxide for one
month prior to circumcision. These antimicrobial agents were selected as they are
licensed and commonly used for the treatment of BV in women or management of
conditions associated with microbial imbalance such as gingivitis/periodontitis (78–
82,82). The impact of these interventions on the availability of HIV target cells in the
foreskin was determined via immunofluorescent microscopy. The impact of the
interventions on HIV target cell availability in the foreskin was further correlated with
impact of interventions on the composition of the penile microbiome and the abundance
of penile inflammatory cytokines assessed by 16S rRNA sequencing and multiplex
enzyme-linked immunosorbent assay, respectively.

2.2 Study Design
2.2.1

Study sites:
Participant enrollment and sample collection was completed at the Entebbe

General Hospital in Uganda. Biological samples were first processed at the Uganda Virus
Research Institute – International Aids Vaccine Initiative (UVRI-IAVI) laboratory prior
to being shipped to the University of Western Ontario (London, Canada), the University
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of Toronto (Toronto, Canada), George Washington University (Washington, D.C, USA),
and Johns Hopkins University (Baltimore, USA) for further analysis.

2.2.2

Study population:
A total of 125 HIV-negative Ugandan men (aged ≥ 18 years) seeking voluntary

PC at Entebbe General Hospital were enrolled in the study (77). Men were invited to
participate in the study during the health education and HIV counseling/testing session
routinely held at the clinic. Potential participants were screened for eligibility (Table 1),
confirmed to be general healthy and without symptomatic genital infections, and willing
to undergo HIV testing. Only men who agreed to provide written informed consent and
demonstrated an understanding of the study (in the opinion of the study team clinical
staff) were invited to participate.

2.2.3

Randomization and blinding
Eligible men (Table 1), who have provided written consent to participate in the

trial were assigned to any of the treatment arms in an open-label fashion using computer
generated randomized numbers. At enrollment, each participant chooses a single
envelope from a pile of sealed-opaque envelopes that have been shuffled by the clinical
staff in the presence of the participant. Each envelope contained a randomly generated
number which determined the participant’s treatment arm assignment.
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Table 1: Inclusion and exclusion criteria
Inclusion Criteria
Aged ≥ 18 years
Male
Uncircumcised
HIV-negative
Willing to give written informed consent
Willing and able to answer a short social-behavior questionnaire
Wiling to comply with study protocol requirements including randomization and
study drug usage
Available for planned duration of randomization group
Exclusion criteria
HIV-infected
Already circumcised
Self-reported or physician noted genital itching/burning, penile discharge, genital
ulceration or other possible sexually transmitted infection symptoms
Participating in other research studies that might compromise the outcomes of
this study
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2.2.4

Treatment group assignment

At enrollment, study participants were randomly assigned to one of five study groups
(n=25 participants per group), as follows:
1. Control group: Participants received no antimicrobial treatment and immediately
underwent circumcision, as per the normal Entebbe General Hospital protocol.
2. Oral tinidazole group: Participants were asked to defer circumcision by 4 weeks
and were provided with oral tinidazole 2g once daily for 2 days. Tinidazole is
commonly used for the treatment of several conditions including amebiasis,
giardiasis, trichomoniasis, and BV. Tinidazole belongs to the imidazole family of
antibiotics, which prevent the growth of Gram-positive and Gram-negative
anaerobic bacteria via disruption of bacterial DNA synthesis (83–85).
3. Topical metronidazole group: Participants were asked to defer circumcision by
4 weeks and were asked to apply 0.75% metronidazole cream topically
underneath the foreskin twice daily for 1 week and then twice weekly for 3
weeks. This formulation of metronidazole is commonly used for the treatment of
BV in women. Metronidazole also belongs to the imidazole family (80,81).
4. Topical clindamycin group: Participants were asked to defer circumcision by 4
weeks and were asked to apply 2% clindamycin cream topically underneath the
foreskin twice daily for 1 week and twice weekly for 3 weeks. Topical
clindamycin is commonly used for the treatment of acne vulgaris and BV.
Clindamycin prevents the growth of many aerobic Gram-positive cocci and
several anaerobic Gram-positive and Gram-negative bacteria by impairing
bacterial protein synthesis (81,86).
5. Topical hydrogen peroxide group: Participants were asked to defer
circumcision by 4 weeks and were asked to apply 1% hydrogen peroxide gel
topically underneath the foreskin twice daily for 1 week and then twice weekly
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for 3 weeks. Hydrogen peroxide gel is a common oral/skin disinfectant typically
used for the treatment of gingivitis/periodontitis. It primarily affects anaerobic
bacteria and kills both Gram-positive and Gram-negative bacteria through the
release of reactive oxygen species that results in the damage of bacterial DNA
(82,87).

2.2.5

Study procedures, visits, and sampling
Potential participants who had clinically apparent symptoms for STIs (genital

ulcerations, urethral discharge, dysuria) were deferred from enrolment and offered
treatment as specified by the Uganda Ministry of Health guidelines. Symptomatic STIs
are also a contraindication for PC, so these individuals were asked to return upon
resolution of symptoms, when they would be eligible for both study participation and PC.
Treatment was also offered for study participants who were found to have asymptomatic
gonorrhea or chlamydia later by polymerase chain reaction (PCR) urine screening. Prior
to randomization, all participants received HIV counseling and testing via rapid
diagnostic tests. A brief social behavioral questionnaire, including sexual history, was
administered and condoms were also provided to all participants. Peripheral venous
blood, urine, and genital swabs from the coronal sulcus, inner foreskin, and urethral
meatus were collected as baseline biological samples. All men in intervention groups
(tinidazole, metronidazole, clindamycin, hydrogen peroxide) had a visit after the
intensive phase of their treatment, on day 3 for men in the tinidazole group (administered
orally) and day 8 for men in the metronidazole, clindamycin, and hydrogen peroxide
groups (administered topically). Men in the metronidazole, clindamycin and hydrogen
peroxide groups received phone call reminders about product use twice a week. A followup visit was scheduled for the men in the intervention groups at 4 weeks after enrollment.
The men were interviewed about product use, tolerability, and sexual practices. During
the visit, repeat blood, urine, and penile swab samples were taken, and the men were
circumcised. The excised foreskin tissues were used for the immunofluorescent
microscopy analysis described in this thesis and were also used by study collaborators in
flow cytometry-based assays.
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2.2.6

Lost to follow-up status and reimbursement

Participants in enrolled in the study were “lost to follow-up” if they did not present to the
clinic within three days of a scheduled date/visit. Participants were reimbursed for their
time of study participation at the end of each clinic visit. Time compensation worth
20,000 UGX (~$7 CND) were provided to each study participant per study visit.

2.2.7

Study outcomes
The overarching objective of the RCT is to determine the impact of antimicrobials

on foreskin HIV susceptibility, penile immunology, and penile microbiota (77). The main
objective of this thesis, which represents one endpoint of the RCT, is to assess the effect
of antimicrobial intervention on foreskin tissue density of HIV susceptible cells (cells
bearing the two receptors used for HIV entry: CD4 and CCR5) based on
immunofluorescence microscopy. Other endpoints of the RCT, which will be investigated
by study collaborators, include determining the effect of the antimicrobial interventions
on (1) viral entry into foreskin-derived CD4+ T cells using a validated primary clad A,
R5 tropic pseudovirus entry assay; (2) proportional abundance of CD4+ T cell subsets
(including Th17 cells) based on flow cytometry of digest foreskin tissue; (3) levels of
soluble immune mediators on the penis, assayed by enzyme-linked immunosorbent assay
(ELISA); and (4) composition of the foreskin microbiome using 16S rRNA sequencing
(52,64,73,74,88–90). Foreskin tissue density of HIV target cells will be correlated with
(1) the abundance of BASIC species and (2) levels of soluble immune mediators as a part
of this thesis project.

2.2.8

Trial status and summary
Study participant enrollment began in December 2017 and was completed in

January 2019. Out of the 125 participants enrolled, 9/125 participants were lost to followup; therefore, the analysis population includes 116/125 participants.
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2.3 Biological sample processing
2.3.1

Blood collection and processing
For each blood draw, clinical staff collected peripheral venous blood from

participants into two 8.5ml BD Vacutainer acid citrate dextrose tubes (Becton, Dickson &
Company, NJ, USA), and blood samples were centrifuged at 2000 x g at 4ºC for 20
minutes to isolate plasma. The plasma samples collected were first stored at -80ºC then
later used for testing of HIV and STIs including herpes simplex virus type 2 (HSV-2) and
syphilis at the UVRI-IAVI laboratory.

2.3.2

Genital swab collection and handling
Genital swab samples were collected in the Entebbe General Hospital

circumcision clinic by rotating pre-moistened Dacron swabs (COPAN Diagnostics Inc.,
CA, USA) on the coronal sulcus (2 swabs), the inner foreskin (2 swabs), and urethral
meatus (1 swab). Immediately after collection, all swabs were placed in clean microtubes
and transported to the UVRI-IAVI laboratory on ice. One swab from the inner foreskin
and one swab from the coronal sulcus was frozen at -80ºC without processing. Each of
the other swabs (1x urethral meatus, 1x inner foreskin, 1x coronal sulcus) were
resuspended in two aliquots 250µl phosphate-buffered saline (PBS) mixed with a
protease inhibitor and buffer before being stored at -80ºC. Swab samples were later
shipped to George Washington University, USA for microbiome analysis and the
University of Toronto, Canada for soluble inflammatory molecule analysis
(52,64,73,88,90).

2.3.3

Urine collection and handling
During the first visit and at the 4-week follow-up, study participants were asked to

self-collect urine in a urine container. Urine samples were transported on ice to the
UVRI-IAVI laboratory and aliquoted into PCR urine tubes (Cobas, Roche Molecular
Systems, Inc) for PCR testing for Neisseria gonorrhoeae and Chlamydia trachomatis.
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2.3.4

Foreskin collection and processing
As previously described, the inner aspect of the foreskin is marked with a suture

during surgery to assist with tissue orientation during processing (91). The inner foreskin
is defined as the portion of the foreskin tissue that covers the glans and coronal sulcus on
the nonerect penis and the outer foreskin is the portion of the foreskin tissue that is
exposed to air on the non-erect penis. After circumcision, foreskin samples were
immediately transported to the UVRI-IAVI laboratory at ambient temperature for
processing. Excess connective tissue and obvious blood clots were first trimmed off from
the tissue before the tissue was cut into 0.25cm2 sections. One 0.25cm2 section from each
of the inner and outer foreskin was separately snap frozen into cryomolds in optimal
cutting temperature compound (OCT) media (Thermo Fisher Scientific Inc., MA, USA).
These samples were shipped to the University of Western Ontario, Canada for the
immunofluorescent microscopy analysis described in this thesis project. One section from
each of the inner and outer foreskin was cryopreserved in 10% dimethyl sulfoxide in FBS
freezing media at -150ºC.
Other tissue sections are digested for flow cytometry analysis. First, 0.25cm2
inner and outer foreskin sections were separately soaked in RPMI 1640 media with
500U/ml collagenase type 1 (Gibco #17100) and 42.5U/ml deoxyribonuclease
(Invitrogen, MA, USA). The soaked tissues were mechanically disrupted using scissors
and then enzymatically digested at 37ºC for 30 minutes at 900rpm on a shaker
(Eppendorf Thermo mixer, Hamburg, Germany). The resulting cell suspensions were
then added to 3ml cold fetal bovine serum (FBS) and filtered through a 100µm cell
strainer (BD Biosciences, NJ, USA). Deoxyribonuclease (30U/ml) was added to the
filtrate and then the cells are washed and resuspended in R10 media (RPMI 1640 media
with 10% heat-inactivated FBS, 10U/ml penicillin, 10µg/ml streptomycin, 250 ng/ml
amphotericin B, and 2mM L-glutamine; Gibco, Invitrogen, Carlsbad, CA, USA) before
being rest overnight at 37ºC under 5% CO2. The rested cells were counted using trypan
blue exclusion and ~10 x 106 cells were plated in 500µl R10 media. Plated cells were
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stained for 30 minutes at 4ºC with labelled monoclonal antibodies for flow cytometry
analysis on-site at the UVRI-IAVI laboratory (49,89).

2.4 Laboratory assays completed by collaborators
2.4.1

Penile microbiome characterization
Penile microbiome characterization was completed using penile swab samples

collected at study enrollment, at one-week post-treatment, and at the time of
circumcision. This analysis was completed by study collaborators at George Washington
University, USA and exact details of the methods used for this analysis are outside of the
scope of this thesis project. Briefly, the penile microbiome was characterized by using
amplicon sequencing and broad-range real-time PCR of the V3V4 hypervariable region
of the 16S rRNA gene as previously described (73,88,90). Barcoded universal primers
specific for the V3V4 hypervariable region were used for sequencing. Amplicons were
purified, quantified, and pooled prior to sequencing on the Illumina MiSeq platform using
the 300bp paired-end protocol. Sequence read quality was assessed using a standardized
bioinformatics pipeline implemented in accordance with standard operating procedures
from the National Institutes of Health Human Microbiome Project. The -utax function in
the USEARCH sequence analysis tool in QIIME (open source microbiome
bioinformatics platform) was used to assign taxonomy and cluster operational taxonomic
units against the Greengenes reference database (92). For each sample, vectors of
phylotype proportions were clustered into community state types, by calculating JensenShannon distances between all pairs of community states and generating a hierarchical
clustering using the Jensen-Shannon distance data and Ward linkage (73,74,88). Through
combining sequencing and qPCR data, the absolute abundance of penile bacterial genus
and species of interest was calculated as follow: absolute abundance of a taxon per swab
= total penile bacterial load per swab (measure as total copied of 16S rRNA gene per
swab by qPCR) x proportional abundance of the given taxon (measure as the number of
16S rRNA gene sequences assigned to a taxon in a given sample, divided by the total
number of 16S rRNA sequences obtained for the sample.
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For the purposes of this thesis, we decided to focus on 1) total bacterial
abundance, 2) BASIC species abundance, and 3) the abundance of bacteria belonging to
two non-inflammatory “control” taxa (Corynebacterium and Staphylococcus), previously
found to be unchanged/increased after circumcision and not previously associated with
HIV seroconversion or inflammation (75). Only five of the six BASIC species were
include in analyses (Peptostreptococcus anaerobius, Prevotella bivia, Prevotella disiens,
Dialister propionicifaciens and Dilaister micraerophilus) as the genetic near neighbour
of Dialister succinatuphilus was excluded due to incomplete data processing. (73,75).

2.4.2

Multiplex ELISA for soluble inflammatory molecule
quantification
Measurement of penile levels of soluble inflammatory molecules was completed

using penile swab samples collected at study enrollment, at one-week post-treatment, and
at the time of circumcision. This analysis was completed by study collaborators at the
University of Toronto, Canada and exact details of the methods used for this analysis are
outside of the scope of this thesis project. Briefly, inflammatory molecule levels will be
measured using a chemiluminescent multiplex ELISA assay (MesoScale Discovery). This
assay was selected due to the ability of providing optimal sensitivity and reproducibility
for low abundance mucosal sample. It has previously been validated for use with foreskin
swab samples (52,73,76).

2.4.3

Pseudovirus cell entry assay
A HIV pseudovirus assay is used to determine the effect of the interventions on

HIV entry into inner foreskin T cells. The assay was completed by study collaborators on
site at the UVRI-IAVI laboratory in Uganda using CD4+ T cells isolated from inner
foreskin samples obtained from circumcision. The exact details on the methods for this
assay are outside of the scope of this project but have been well characterized in previous
studies (49,89). The virus used for this assay contains a β-lactamase-viral protein R
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(BlaM-Vpr) and is pseudotyped with an envelope from an early transmitted, CCR5tropic, subtype A virus. When the pseudovirus enters target cells, BLaM-Vpu is delivered
into the cytosol. After target cells have been incubated with the pseudovirus, the substrate
CCF2-AM is added. CCF2 is a membrane-permeant form of the fluorescent molecule
CCF which contains 2 fluorophores (7-hydroxy-coumarin and fluorescein) linked by a βlactam bond. Cells that were not infected by the pseudovirus will not have β-lactamase in
the cytosol. In these cells, excitation of 7-hydroxy-coumarin at 409nm leads to
fluorescent resonance energy transfer (FRET) to fluorescein and green light emission at
520nm. Infected cells will have β-lactamase in the cytosol (via delivery from BLaMVpu) that will cleave the β-lactam bond in CCF2-AM and prevent FRET. This results in
blue emission at 447nm by 7-hydroxy-coumarin when 7-hydroxy-coumarin is excited.
The ratio of blue to green emission can thus be used as a measure of viral fusion and
cytosolic entry of HIV.

2.5 Statistical and ethics considerations
2.5.1

Sample size
The sample size of 25 participants per treatment group for the RCT was based on

the primary endpoint, which was the HIV pseudovirus assay. Previously defined
pseudovirus entry parameters into inner foreskin-derived CD4+ T cells suggested that a
sample size of 25 participants per group would provide statistical power of 80% to
identify clinical approaches that reduce virus entry by ≥33%. This was the efficacy
threshold that was deemed as sufficient to inform future intervention strategies. All
available samples (n=116) were used for the IF analysis presented in this thesis.

2.5.2

Ethics and Patient involvement
The RCT protocol was reviewed and approved by the Ugandan Virus Research

Institute’s Research and Ethics Committee (UVRI SEC), the Ugandan National Council
for Science and Technology (UNCST), and the University of Toronto HIV Research
Ethics Board. The data and biological samples collected from study participants were

19

labelled with a unique study identification number. All clinical events that were directly
related to the study were referred to and managed by the UVRI-IAVI clinical team
according to the Ugandan Ministry of Health guidelines. Participants in the study were
not directly involved in the design of this study and did not directly assess the effect of
the interventions. Participants did play a role in contributing to peer referral of potential
participants. The Community Advisory Board for UVRI-IAVI meets quarterly and
provided advice to the study team on study design and recruitment. The protocol for
analysis of frozen tissue sections by IF (and correlation with data generated by
collaborators) was approved by the Research Ethics Board at The University of Western
Ontario.
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Chapter 3

3

Comparison between a deep-learning and a pixelbased approach for the automated quantification of HIV
target cells in foreskin tissue.

3.1 Introduction
3.1.1

Understanding HIV infection at the site of exposure
Sexual transmission of HIV, which occurs at the anogenital mucosa, accounts for

the vast majority of new HIV infections worldwide (93,94). After HIV virions penetrate
the genital epithelium, the availability of target cells bearing the HIV co-receptors CD4
and CCR5 becomes the critical determinant of productive infection in mucosal tissue
(Figure 1) (30,38,95,96). The inner foreskin is enriched in T cell populations that are
highly susceptible to HIV, such as activated T cells and Th17 cells, compared to the
bloodstream (28,30,32). Non-T cell types that are abundant in the foreskin, such as
macrophages, dermal dendritic cells, Langerhans cells and fibroblasts, are also thought to
facilitates the spread of viral infection, either by direct infection or by transferring viral
particles to susceptible T cells through trans-infection (Figure 1) (97,98). The genital
mucosa is also inhabited by diverse polymicrobial communities of bacteria that shape the
local immune environment. The composition of the genital microbiome has been shown
to be associated with both the availability and activation status of HIV target cells, and
with an individual’s risk of acquiring HIV during sex with an infected partner
(73,75,95,99). Achieving an optimal balance between the diverse immune cell subsets of
the genital mucosa promotes tolerance to commensal bacteria while maintaining the
ability to rapidly respond to pathogens. An inflammatory environment in the genital
mucosa promotes productive infection with HIV, while a tolerogenic environment is
associated with relative protection (100,101). The genital mucosa is in constant contact
with antigens, antimicrobial factors, hormones, and commensal bacteria that can
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modulate the local environment of genital mucosa to a pro-inflammatory state and in turn
modulate and individual’s risk to HIV infection (24,37,64,73–75). When testing new
prevention modalities or determining best practices to prevent HIV transmission, it is
essential to develop ways to quantify immune cells in mucosal tissue, to better understand
how behaviours, medications, etc. influence the abundance of HIV target cells in the
mucosa.

3.1.2

Using immunofluorescent microscopy to quantify immune
cells in the genital mucosa
High-parameter flow cytometry has been actively used in studies focused on HIV

detection, susceptibility, prevention, and pathogenesis. Advancements in CD4 T cell
laboratory testing and the detection of HIV-infected mononuclear cells in the
bloodstream were critical developments for the care and management of HIV infected
individuals (102,103). Flow cytometry is highly useful for understanding immune cell
populations and HIV infection in peripheral blood as it allows quantification of multiple
target cell types of interest and the simultaneous detection of a large variety of different
cell markers on single cells. While flow cytometry is advantageous for the study of
immune cells in blood, it is less suitable for mucosal tissues (104–107). Due to the nature
of flow cytometry, tissues must be mechanically or enzymatically disrupted into single
cell suspensions so information on the spatial location of cells within tissue is lost. This is
a disadvantage in the context of susceptibility to viral infection, as the closer target cells
are to the apical surface of the epithelium the less distance a virion needs traverse to
access susceptible cells (42,52). Information on the proximity of immune cell subsets to
one another is also lost, which is important for understanding immunological events such
as immune cell activation, antigen presentation, and trans infection of HIV
(64,75,108,109). In addition to losing spatial information, the viability of delicate
sprawling cells that are abundant in the foreskin mucosa, such as dendritic cells and
Langerhans cells, is reduced due to the disruption process. Tissue disruption may also
alter expression of cell surface markers relevant to activation and viral entry. Lastly, flow
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cytometry provides information on the relative abundance of immune cell subsets but is
ill suited for measuring the density of immune cells in tissue.
Immunofluorescent (IF) imaging overcomes the limitations imposed by tissue
disruption but introduces new challenges in quantification. Structural proteins and
collagen fibers, which are abundant in genital mucosal tissue, exhibit high levels of
autofluorescence that can obscure positive staining and make cell identification difficult
(Figure 2). Autofluorescence is highly variable in different tissue regions in the same
sample and among samples from different individuals (28,30,110). Due to the difficulty
of cell quantification and the high level of variability in IF images, manual counting is
still a common practice despite its lack of efficiency and issues with bias. A single 8µm
thick section of a 5mm x 5mm piece of genital tissue contains thousands of immune cells.
In many cases, instead of quantifying whole tissue section images, randomly selected
field-of-views (FOV) that are a fraction of the size of each whole image are quantified
instead. However, by reducing the “sample size” of tissue analyzed precision is lost and
random noise introduced into the data, reducing statistical power. Furthermore, manual
counting also suffers from reproducibility issues, investigator bias, and inter-investigator
variability which becomes highly problematic in clinical studies where large numbers of
samples are involved. To overcome these issues, significant effort has been made to
automate image processing and cell segmentation in recent years.
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Figure 1: Visualization of the epidermis and dermis in foreskin tissue. The epidermis
is characterized by a very high density of nuclei staining which represents tightly packed
epithelial cells while cells are more dispersed in the dermis. HIV susceptible immune
cells can be found in both the epidermis and dermis. However, they are usually more
abundant in the dermis, particularly in areas of the dermis that are close to the basal edge
of the epidermis.
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Figure 2: Representative images of inner and outer foreskin tissue sections stained
for the identification of HIV target cells. Images were obtained from foreskin tissue
sections from HIV-negative men in a randomized controlled trial assessing the effect of
antimicrobials on the penile microbiome, penile inflammation, and foreskin HIV
susceptibility. Foreskin tissue sections were stained for CD3, CD4, CCR5, and nuclei to
identify HIV susceptible cell populations. Whole (A) inner and (B) outer foreskin tissue
imaged at 200x total magnification. Individual staining for CD3, CD4, CCR5, and nuclei
is shown on the left while merged composite of positive staining from all channels is
shown on the right. White letters mark areas containing cell clusters that are likely to
contain (T) HIV-susceptible CD4+CCR5+ T cells and areas with (F) significant
autofluorescence.
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3.1.3

Existing strategies for automated cell segmentation in
immunofluorescent microscopy images of mucosal tissue
Several medical image analysis companies offer software products that can

perform automated cell counting in IF images. However, these products are limited by
poor flexibility for modification by the user and high cost (111,112). Custom cell
counting workflows based on free open-source image analysis software programs such
ImageJ/Fiji, CellProfiler and QuPath are commonly used for cell segmentation in a large
variety of tissue types (Figure 3) (113–115). Workflows based on these programs are
highly flexible as these programs contain many image processing functions with
adjustable input parameters. Furthermore, only basic programming knowledge is required
to automate workflows built on these programs to achieve high-throughput processing of
images.
Traditional cell segmentation workflows typically use a “bottom-up” pixel-based
strategy. In these pixel-based approaches, a threshold is applied so that every pixel is
classified as positive staining or background (i.e., converted to a binary, or black-andwhile image). Images may also undergo additional processing before or after thresholding
to improve pixel classification. Separate clusters of positive pixels are then identified as
individual cells (Figure 3B) (116–118). While this basic approach is very easy to
implement and generates good results in cases where cells are very clearly isolated from
one another, it struggles with images that have variable brightness (e.g., variable
expression of the target protein between cells/regions), densely packed or irregularly
shaped cells, or high levels of autofluorescence (119). All these features are common in
IF images of genital mucosal tissue. In many cases, it is very difficult or impossible to
find a combination of parameters that will accurately detect cells across all areas of the
tissue and all tissues in the study (120). When image processing is not aggressive enough,
closely packed cells may be merged and large amounts of autofluorescence could be
incorrectly identified as positive staining. Aggressive image processing is effective in
eliminating autofluorescence but can also result in elimination of true cell staining and
result in splitting of whole cells into several fragments.
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Advances in deep learning have enabled “top-down” object-based approaches for
cell segmentation. In these approaches, a prediction is made to identify individual cells
(objects) with rough shape representations that are progressively refined to fit cells more
closely. These approaches use training input to develop segmentation parameters which
correspond to features. Initial attempts at using machine learning for cell segmentation
used bounding boxes to create cell selections. (121–123). In the prediction phase of these
approaches, a cell is identified with several overlapping instances of bounding boxes
representing all possible ways the cell could be identified (Figure 3C). The best fitting
box out of all the bounding boxes is then selected using a technique called non maximum
suppression (NMS) (124). This approach is good at distinguishing between
autofluorescence and positive cell staining, however, it is inaccurate in areas with densely
packed cells. In these areas, bounding boxes can be incorrectly eliminated by NMS when
there is overlap between bounding box selections for different cells (Figure 3C).
Recent studies have proposed better shape representations to replace bounding
boxes. For instance, the deep learning segmentation method StarDist uses star-convex
polygons to identify cells (125). Star-convex polygons are well suitable for
approximating the shape of important HIV target cells. It can match the blob-like shape
of CD4+ T cells and also maintain enough flexibility to outline sprawling cells like
macrophages and dendritic cells. The sophisticated prediction process used by StarDist
enables more accurate prediction of cell boundaries and better performance in areas with
high cell density (Figure 3D). Implementation of StarDist deep learning models into
existing IF image analysis workflows is also user-friendly. While training new StarDist
models requires knowledge of python, no programming experience is required to use
existing StarDist models. Software plugins allow existing StarDist models to be used in
image processing programs such as ImageJ/Fiji and QuPath (113,115,125).
The StarDist method has previously been validated for nuclei segmentation and
cell detection in different tissues. However, StarDist has not previously been used to
identify immune cells in IF microscopy images of genital mucosal tissue. In this chapter,

27

we describe the training and validation of a StarDist model to identify HIV target cells in
foreskin tissue. Specifically, we introduce a reusable workflow that can be used to train
custom StarDist models. This workflow uses multi-channel IF microscopy images as
input and is not limited by the tissue type or markers used for staining. We describe the
training of a custom StarDist model used to identify HIV target cells in foreskin tissue
stained for CD3, CD4, CCR5, and nuclei. The accuracy of this StarDist model was
compared to manual counting and automated counting using a previously established
pixel-based algorithm. The training workflow, training dataset and StarDist model used
in this thesis have been made available in the public domain
(https://github.com/prodgerlab/stardist).
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Figure 3: Common methods used for automated cell segmentation in
immunofluorescent microscopy images of mucosal tissue. (A) Sample
immunofluorescent microscopy image of nuclei staining in a tissue area with high cell
density. Early methods of automated cell segmentation utilize (B) pixel-based bottom-up
approach where cells are defined by pixels that are above a certain intensity threshold.
These methods tend to be very crude and can results in cell merging or splitting. (C) The
first deep learning approaches utilizes bounding boxes to first localize cells. This
approach does not rely on a bottom-up approach. However, bounding boxes can overlap
in areas where cells are closely packed and result in the suppression of valid cell
instances during the process of non-maximum suppression. Boxes in yellow represent
correctly placed bounding boxes, boxes in purple represent valid cell instances that were
suppressed. (D) Deep learning cell segmentation with StarDist utilizes star-convex
polygons instead of boxes to create predictions.
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3.2 Materials and Methods
3.2.1

Tissue Source
Foreskin samples were collected as a part of a randomized clinical trial (RCT)

examining the effect of antimicrobials on the penile microbiome, foreskin inflammation,
and foreskin HIV target cell density (77). Detailed information on the RCT methodology
can be found in Chapter 2 in sections 2.2.1 to 2.2.8. In brief, a total of 125 HIV-negative
men (≥18 years) seeking voluntary male circumcision were enrolled and randomly
assigned to 1 of 5 treatments (topical clindamycin, topical hydrogen peroxide, topical
metronidazole, oral tinidazole) or no treatment, prior to circumcision.

3.2.2

Immunofluorescence microscopy
Tissue samples from the study were separately stained using two different

antibody panels to investigate the effect of the interventions on: 1) foreskin tissue
integrity and 2) foreskin HIV target cell density, respectively. Staining, imaging, and
analysis for the assessment of tissue integrity was completed as a part of another study
and is outside the scope of this project. Staining and imaging of tissue samples to
quantify target cell populations was completed according to previously published
methods and are described below (126).
Cell markers of interest captured by the antibody panel used to quantify HIV
target cell populations include CD3, CD4, and CCR5. Foreskin samples from 116/125
participants enrolled in the RCT were available for immunofluorescent microscopy
analysis. One inner foreskin sample and one outer foreskin sample was analyzed for each
participant meaning a total of 232 foreskin tissue samples were analyzed as a part of this
project. Frozen tissue blocks were prepared in the UVRI-IAVI laboratory in Uganda
immediately after circumcision and then shipped to the University of Western Ontario in
Canada for immunofluorescent microscopy analysis. Frozen tissue blocks were sectioned
at a thickness of 8µm using a CM1850 cryostat (Leica, Wetzlar, Germany) and two
sections from each tissue block were adhered to a microscopy slide for staining. Slides
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were stored at -80 ºC for up to 1 month in an air-tight box. Prior to staining, slides were
thawed and air-dried for 30 minutes. Each tissue section was fixed by applying 100µl of
3.7% formaldehyde in PIPES (100mM PIPES, 2mM MgCl2, 1mM EGTA in PBS, pH
6.8) buffer and incubation for 5 minutes at room temperature. Slides were washed 3 times
in 1x PBS between all subsequent blocking and staining steps. Each tissue section was
blocked by applying 100µl of a solution consisting of 10% normal donkey serum, 0.1%
Triton X-100, and 0.01% sodium azide diluted in 1x PBS (henceforth referred to as
blocking solution) for 30 minutes at room temperature. Each section was incubated with
100µl of undiluted anti-human primary CD3 antibody (Abcam, Cambridge, United
Kingdom) for 1 hour at 37 ºC, followed by incubation with 100 µl of donkey anti-rabbit
Alexa Fluor 488-conjugated secondary antibody (diluted to 0.25% in blocking solution)
(Abcam, Cambridge, United Kingdom) in the dark for 30 minutes at room temperature.
Next, sections were each incubated with 100µl of mouse anti-human CCR5 primary
antibody (diluted to 5% in blocking buffer) (a gift from Dr. Matthias Mack, University of
Regensburg, Germany) for 1 hour at 37 ºC, followed by incubation with 100 µl of donkey
anti-mouse Alexa Fluor 647-conjugated secondary antibody (diluted to 0.25% in
blocking solution) (Abcam, Cambridge, United Kingdom) in the dark for 30 minutes at
room temperature. Finally, sections were each incubated with 100 µl goat anti-human
CD4 primary antibody (diluted to 5% in blocking buffer) (Abcam, Cambridge, United
Kingdom) overnight at room temperature then incubated with 100 µl of donkey anti-goat
Alexa Fluor 568-conjugated secondary antibody (diluted to 0.25% in blocking buffer)
(Abcam, Cambridge, United Kingdom) in the dark for 30 minutes at room temperature.
Coverslips were mounted onto stained slides by applying 100 µl Fluoromount G
mounting media with DAPI (Thermo Fisher Scientific, MA, USA) per slide. Slides were
stored at 4 ºC for up to one week prior to imaging. Tiled images for whole tissue sections
were scanned with a DM5500B fluorescence microscope (Leica, Wetzlar, Germany)
using the 20x objective lens for CCR5 (Y5 filter set, referred to as far-red channel), CD4
(DSR filter set, referred to as red channel), CD3 (GFP filter set, referred to as green
channel), and cell nuclei (CFP filter set, referred to as blue channel). Excitation and
emission filters are listed in Table 2.
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Table 2: List of microscope filters and their designations
Leica Filter

Absorbance

Excitation

Emission

Emission

Emission

Designation

λ

Filter*

λ

Filter*

Colour

DAPI

CFP

358

436/20

461

480/40

Blue

Alexa Fluor 488

GFP

494

425/60

517

480/LP

Green

Alexa Fluor 546

DSR

556

545/30

573

620/60

Red

Alexa Fluor 647

Y5

650

620/60

665

700/75

Far-Red

Fluorophore

Note: LP (long pass filter), λ (wavelength in nanometers)
*peak wavelength of light that passes through the filter and filter bandwidth
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3.2.3

Manual counting of HIV Target Cells
All possible cell type combinations from the foreskin tissue sections stained for

CD3, CD4, CCR5, and nuclei were counted individually (all cells, CD3+ cells, CD4+
cells, CCR5+ cells, CD3+CD4+ cells, CD3+CCR5+ cells, CD4+CCR5+ cells, and
CD3+CD4+CCR5+ Cells). Total cell count was determined by counting all positive
stained nuclei. Counting of specific cell types was completed using composite images
containing staining for nuclei and the marker(s) of interest. First, composite images
containing the staining for the markers of interest were generated from raw 4-channel
(channels: CD3, CD4, CCR5, Nuclei) images. For each 4-channel sample image, 7
different composites corresponding each of the cell types of interest were generate (CD3+
cells, CD4+ cells, CCR5+ cells, CD3+CD4+ cells, CD3+CCR5+ cells, CD4+CCR5+
cells, CD3+CD4+CCR5+ cells). As mentioned, each composite image is created from
merging the channel image(s) for the marker(s) of interest with the channel image for
nuclei staining. For example, the composite image for CD3+ cells was created by
merging the CD3 channel with the nuclei channel. Counting was completed by a single
trained lab member using the Cell Counter plugin for Fiji. A cell is positive for a marker
of interest when positive marker staining directly overlaps/surrounds positive nuclei
staining. Positive marker staining that are unassociated with nuclei were ignored.

3.2.4

Pixel-based cell counting using Fiji and CellProfiler
A pixel-based cell counting algorithm used to quantify HIV target cells in

immunofluorescent microscopy images of foreskin tissue stained for CD3, CD4, CCR5,
and nuclei was previously validated by our group (126). This algorithm was is based on
the open-source image analysis programs Fiji and CellProfiler (113,114). Image
processing functions in Fiji were used to pre-process images. Both Fiji and CellProfiler
were used for thresholding and cell segmentation after pre-processing (113,114). The
epidermis and dermis of foreskin tissue are very different in terms of cell density and
level of autofluorescence. To improve the accuracy cell segmentation using the pixel-
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based workflow, the epidermis and dermis underwent pre-processing, thresholding and
segmentation using different parameters.
Prior to pre-processing, full tissue section scans were split into the dermis and
epidermis sections via manual tracing in Fiji and saved as separate files. The epidermis
and dermis images were then split into individual channel images (CD3, CD4, CCR5,
nuclei) by applying the “Stack to Images” function in Fiji. All individual channel images
were pre-processed by applying the “Subtract Background”, “Brightness/Contrast”, and
“Minimum Filter” functions successively. The “Subtract Background” function and
“Minimum Filer” functions were applied using the corresponding pre-optimized
parameters as listed in Table 3, the “Auto” setting was used for used for all
“Brightness/Contrast” adjustments.
Image processing functions in Fiji and CellProfiler were used successively in
order to automatically quantify HIV target cells in the pre-processed images (113,114).
Fiji was used to threshold pre-processed images and select positive staining. CellProfiler
was used to quantify cells of interest by determining the number of instances where each
combination of positive marker staining for CD3, CD4, and CCR5 overlapped with
positive staining of nuclei. In Fiji, pre-processed images were converted to 8-bit format
and the “Adaptive Thresholding” plugin for ImageJ was used in Fiji to threshold images
(113,127). The “Fill Holes”, “Despeckle”, “Erode”, and “Watershed functions were then
applied successively in Fiji to further process the images. Positive marker staining
selection was completed by applying the “Analyze Particles” function with the options
for “Display Results”, “Clear Results” and “Add to Manager” checked and the
“Circularity” setting set from 0.00 to 1.00 to detect all objects. The regions-of-interest
(ROIs) generated after applying the “Analyze Particles” function were saved and
overlayed with a black 8-bit image with the same dimensions as the image being
analyzed to create a binary image representing positive marker signal. The number of
regions-of-interest for nuclei staining represents the total cell count of the image. The
steps described above were applied to all pre-processed images with pre-optimized
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parameters listed in Table 4. Specifically, predetermined values were used for the “Block
Size” and “Subtraction Value” parameters for “Adaptive Thresholding” and
predetermined values were used for the “Particle Size” parameters for “Analyze
Particles”. The binary black and white images of positive marker staining were imported
into CellProfiler using the “ConvertImageToObjects” function. The “RelateObjects”
function was then applied to determine positive marker staining for CD3 and/or CD4
and/or CCR5 that overlaps with positive nuclei staining (113,114). Through this process,
the number of each type of cell of interest (CD3+ cells, CD4+ cells, CCR5+ cells,
CD3+CD4+ cells, CD3+CCR5+ cells, CD4+CCR5+ cells, CD3+CD4+CCR5+ cells) was
quantified. Scripts for high-throughput pre-processing and automated counting of images
has been made available in the public domain (https://github.com/prodgerlab/pixel-basedquantification).
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Table 3: Input parameters for pre-processing workflow used to improve accuracy of
automated HIV target cell segmentation in foreskin tissue scans
Image Type

EPIDERMIS

Function

Subtract
Background

Minimum
Filter

Input
Parameter

Dermis

Nuclei

CD3

CD4

CCR5

Nuclei

CD3

CD4

CCR5

10

14

12

10

25

15

15

15

0

2

1

0.5

2

2.5

1.5

1.5

Rolling
Ball
Radius

Radius

Table 4: Input parameters for thresholding and segmentation for pixel-based
quantification of HIV target cells in foreskin tissue scans
Image Type

EPIDERMIS

Function

Input
Parameter
Block Size

Dermis

Nuclei

CD3

CD4

CCR5

Nuclei

CD3

CD4

CCR5

100

100

100

100

100

100

100

100

-5

-45

-10

-25

-30

-40

-35

-20

5

7

10

7

5

10

5

10

to ∞

to ∞

to ∞

to ∞

to ∞

to ∞

to ∞

to ∞

Adaptive
Thresholding

Subtraction
Value

Analyze
Particles

Particle Size
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3.2.5

Annotation of images for StarDist model training in Labkit
Manual annotation of field-of-view (FOV) images for StarDist model training was

completed using the Labkit plugin (version 0.3.7) for Fiji (113,128). Manual annotation
was completed by 2 different trained lab members following the instructions listed in the
StarDist GitHub repository (https://github.com/stardist/stardist).
A total of 40 FOVs were randomly generated from the whole tissue section scans
from the randomized controlled trial for training. We randomly selected 40 out of the 232
whole tissue section scans for FOV generation and created a random crop (600x600µm,
1500x1500 pixels) from each selected image. Prior to annotation, all FOVs were visually
assessed to ensure that none of the FOVs included any areas with tissue folding from
improper adherence of tissue sections to microscopy slides during cryosectioning. The 40
FOVs included inner and outer foreskin images from all 5 groups in the randomized
controlled trial. The full thickness of the epidermis is included in each FOV image (both
the apical and basal edge of the epidermis is clearly identifiable) while at least half of the
full thickness of the dermis is included. All FOVs underwent manual counting prior to
annotation. This counting process was completed to ensure the accuracy of annotation.
All possible cell type combinations were annotated individually in each FOV. From each
4-channel raw FOV image, 7 composite images were generated and annotated separately.
The 7 different composite images corresponded to the 7 different cell types that are
identified by our StarDist model (CD3+ cells, CD4+ cells, CD3+CD4+ cells,
CD3+CCR5+ cells, CD4+CCR5+ cells, CD3+CD4+CCR5+ cells). The channel image
for nuclei staining was annotated to train the model to determine total cell count. This
means that a total of 320 (280 composite images, 40 raw nuclei staining images) were
annotated with 40 images corresponding to each of the cell types of interest.
FOVs were opened in the Labkit plugin (version 0.3.7) for Fiji for annotation
(113,128). All cells, which included cells on the image border, were manually traced and
assigned an individual label with the override option selected to prevent overlapping
cells. Completed annotation images were saved as separate tiff files. Each annotated set
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used for training included 1 raw 4-channel FOV image and 8 annotated images
(considered as ground truth for training).

3.2.6

StarDist model training
Training of the custom StarDist model was completed using a CUDA enabled

Windows 10 workstation computer running a Window Subsystem for Linux with the
Ubuntu (version 22.04) distribution of Linux installed. This workstation computer was
equipped with an NVIDIA GeForce RTX 3090 graphics card to accelerate model
training. The training environment, all scripts, and all additional software packages used
for model training were operated in the Ubuntu distribution of Linux (version 22.04). The
training environment was set up using the Mambaforge (version 0.24.0) distribution of
Python (version 3.10.5) for Linux and TensorFlow (version 2.10.0) through a custom
workflow created using Snakemake (version 7.12.0). Snakemake is a popular workflow
management system commonly used for data analysis (129). It uses a simple
specification language on top of Python to organize data analysis. Configuration of the
necessary software packages, initialization of the training environment, running the
training/validation scripts, and export of the trained StarDist model was streamlined with
Snakemake through a Snakefile. The Snakemake workflow used to set up the training
environment was adapted from instructions from the StarDist GitHub repository
(https://github.com/stardist/stardist) which originally described set-up of a Python
training environment using the Anaconda distribution of Python. Our full Snakemake
workflow, which includes all scripts used for model training and export, has been make
available in the public domain (https://github.com/prodgerlab/stardist).
The scripts used for model training and export were also adapted from example
Jupyter notebooks from the StarDist repository, which provided instruction for 2D (UNet-based) StarDist model training. Adjustments were made so that immunofluorescent
microscopy images with 4 channels can be used as input. We also adapted the image
augmentation functions included in the example Jupyter notebook and included these
functions in our training script. Data augmentation includes random flipping and intensity
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modification to training images, this process improves the accuracy of the StarDist model
without the need for additional training images and annotation. Training was completed
with the n_rays parameter for Config2D set to 32 and all other parameters were left to
their default value in accordance with the Jupyter notebook in the StarDist GitHub
repository (https://github.com/stardist/stardist). The full dataset used for training has been
made available in the public domain (https://zenodo.org/record/7030912#).
Model training was performed for 400 epochs with steps per epoch set to 100.
The model was exported after the probability and overlap parameters for non-maximum
suppression post-processing were optimized. These optimized NMS parameters were
used when using the model in the StarDist plugin (version 0.6.0) for Fiji (113,125). When
using the model for prediction, images fed into the model were first normalized with the
percentile range for image normalization was set from 1.7 to 99.8. The model was then
run with the probability/score threshold set to 0.50, the overlap threshold set to 0.70.
number of tiles was set to 16 and boundary exclusion was set to 2. Our trained StarDist
model with optimized parameter pre-loaded has be made available in the public domain
(https://zenodo.org/record/7030912#).

3.2.7

StarDist model validation
We compared the performance of our StarDist model against manual counting

and pixel-based automated cell counting using 10 FOV images. The FOV images used
for validation were randomly generated from the randomized controlled trial sample
images in the same fashion as the FOVs used for StarDist model training. Both inner
foreskin images and outer foreskin images were used to make validation FOVs and each
of the validation images were derived from RCT sample images that were not used to
make model training FOVs. Like the model training FOV images, validation FOVs were
600x600µm (1500x1500 pixels) in size, excluded areas with tissue section folding,
included the full thickness of the epidermis (apical and basal edge could both be clearly
identified), and included at least half of the thickness of the dermis. Manual counting of

39

the validation images was completed by one trained lab member following the
instructions described in section 3.2.3.
The percent difference between 1) manual counting and pixel-based automated
counting, and the percent different between 2) manual counting and StarDist deeplearning automated counting was determined. The total number of true positive, true
negative, false positive, and false negative counts were determined from the pixel-based
and StarDist counts through comparison with manual counts. Key metrics such as
sensitivity, precision, false negative rate, and false discovery rate was determined for the
pixel-based counting algorithm and StarDist deep-learning counting algorithm.

3.2.8

StarDist model performance in high autofluorescence or high
cell density areas
Four image crops containing an area with high autofluorescence (70x70µm,

175x175 pixels) and Four image crops containing an area with high cell density
(70x70µm, 175x175 pixels) was created from each of the 10 validation FOV images (600
µm, 1500x1500 pixels). Image crops were created such that there was no overlap
between the image crops generated from the same validation FOV. This means that none
of the high autofluorescence image crops overlapped with each other and none of the
high cell density image crops overlapped with each other. A total of 40 high
autofluorescence image crops were analyzed and a total of 40 high cell density image
crops were analyzed. High autofluorescence image crops and high cell density image
crops were analyzed using both the StarDist algorithm and pixel-based algorithm.
Performance of the StarDist counting method and pixel-based counting method in areas
of high autofluorescence was visually assess by determining the number of image crops
where autofluorescence was inaccurately counted as a cell (113,125,126). Performance of
the StarDist counting method and pixel-based counting method in areas of high cell
density was visually assessed by determining the number of instances of where cells were
falsely merged in all 40 high cell density image crops.
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3.2.9

Statistical Analysis
Results are presented as mean ± SDs. Difference between number of counts

between pixel-based automated counting and manual counting and difference between
number of counts between StarDist automated counting and manual counting was assess
using paired T tests. Statistical analysis was performed using Prism 9 (GraphPad
software, La Jolla, CA, USA). All figures were also generated using Prism 9. Results
were statistically significant if the p-value was less than 0.05.
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3.3 Results
3.3.1

Automated HIV target cell segmentation using StarDist is
comparable to manual counting and more accurate than
pixel-based cell segmentation
To determine if the performance of our custom StarDist model is comparable to

manual counting and exceeds the performance of a previously validated pixel-based
workflow, we completed manual counting, automated segmentation using StarDist, and
automated segmentation using a pixel-based method for 10 FOV images (600x600µm
each) of foreskin tissue stained for HIV target cells (staining for CD3, CD4, CCR5, and
nuclei) (Figure 4). Pairwise comparison of manual counts with counts generated with our
StarDist model showed that total cell count and counts for all cell types of interest (CD3+
cells, CD4+ cells, CCR5+ cells, CD3+CD4+ cells, CD3+CCR5+ cells, CD4+CCR5+
cells, CD3+CD4+CCR5+ cells) were not significantly different between the 2 methods
(p>0.05) (Figure 5). Automated counts generated with the pixel-based workflow were
not significantly different (p>0.05) from manual counts for total cell count, CD3+ cells,
and CD4+ cells. However, automated counts generated using the pixel-based method for
all other cell types were significantly different from manual counts. Specifically,
automated counts for CCR5+ cells (p=0.0043), CD3+CD4+ cells (p=0.0058),
CD3+CCR5+ cells (p=0.0004), CD3+CD4+CCR5+ cells (p=0.0005) were significantly
lower than manual counts while automated counts for CD4+CCR5+ cells (p=0.0245)
were significantly highly than manual counts (Figure 5).
Overall, based on pooled counts from all 10 validation FOVs, the percent
difference of StarDist counts from manual counts was less than 5% for all cell types
except for CD4+CCR5+ cells (11.32%) and CD3+CD4+CCR5+ cells (13.59%).
Meanwhile, percent difference of counts generated using the pixel-based approach from
manual counts was less than 5% only for total cell count and CD3+ cell count. The
percent difference of CCR5+ cell count, CD3+CD4+ cell count, CD3+CCR5+ cell count,
CD4+CCR5+ cell count, and CD3+CD4+CCR5+ cell count from manual counts for were
all over 12%. In particular, the percent difference of CD3+CD4+CCR5+ cell counts from
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manual counts was 24.9%. Generally, the percent difference from manual counts of
automated counts generated with the pixel-based approach ranged between 1.25
(CD4+CCR5+ cells) to 8.4 times (CCR5+ cells) greater than automated counts generated
with StarDist (Table 5). Automated cell segmentation of HIV target cells in foreskin
tissue using our custom StarDist model had higher sensitivity and precision than
automated cell segmentation using a pixel-based approach for all cell types. The
sensitivity of our custom StarDist model was over 94% for counts of all cell types and
over 97.5% for CD3+CCR5+ cell counts, CD4+CCR5+ cell counts, and
CD3+CD4+CCR5+ cell counts. Meanwhile the sensitivity of the pixel-based workflow
was less than 85% for all cell types except for counts for total cell count (93.58%) and
CD3+ cells (91.10%). In particular, the sensitivity of the pixel-based approach for
CD3+CD4+CCR5+ cells was only 60.70%. Precision wise, both StarDist and the pixelbased method had over 90% precision for all cell types except for CD4+CCR5+ cells and
CD3+CD4+CCR5+ cells (87.94% and 85.19% respectively for StarDist, 69.77% and
77.96% respectively for the pixel-based workflow) (Table 6).
StarDist also had a lower false negative rate and lower false discovery rate than
the pixel-based approach for counts all cell types. The false negative rate of automated
cell segmentation using the StarDist model was under 5.2% for all cell types while the
false negative rate for the pixel-based workflow was between 6.42% (total cell count) and
39.30% (CD3+CD4+CCR5+ cells). Overall, the false discovery rate for the pixel-based
workflow was 1.7 (CD3+ cells) to 16.4 (CD3+CD4+CCR5+ cells) times higher than
automated cell segmentation using our custom StarDist model. The false discover rate of
both methods of automated cell segmentation was under 10% for all cell types except for
CD4+CCR5+ cells and CD3+CD4+CCR5+ cells (12.06% and 14.81% respectively for
StarDist, 30.23% and 22.04% respectively for the pixel-based approach) (Table 5).
Quantification of HIV target cells using StarDist appeared to be comparable to
manual counting and the performance of the StarDist model exceeded the performance of
pixel-based cell segmentation by all metrics we examined.
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Figure 4: Automated segmentation of HIV target cells in foreskin tissue images
stained for CD3, CD4, CCR5 and nuclei using a pixel-based workflow and StarDist.
(A, E) Representative image of (A) nuclei staining and (E) composite image of staining
for CD3, CD4, CCR5, and nuclei were generated from a cropped image of a full tissue
section scan of foreskin tissue imaged at 200x total magnification. Visual representation
of (B-D) counting of all positively stained nuclei and (F-H) counting of all
CD3+CD4+CCR5+ cells in the representative image. Methods of cell segmentation
presented include (B, F) Manual counting of cells, (C, G) automated counting using a
pixel-based approach, and (D, H) automated segmentation using a custom StarDist deeplearning model.
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Figure 5: Comparison of automated counts generated using StarDist with manual
counting and automated counts generated using a pixel-based workflow. Cell
counting was completed on 10 validation field-of-view images (600x600µm) randomly
generated from a set of 232 full foreskin tissue section scans stain for CD3, CD4, CCR5,
and nuclei to identify HIV susceptible cells in the tissue. Full tissue section scan images
were originally imaged at 200x total magnification. The 10 validation images include
both inner foreskin and outer foreskin images. Manual counting of images was completed
by 1 observer. Manual counts are represented by black dots while automated counts
produced using a pixel-based workflow and StarDist are represented by pink and cyan
dots respectively. Gray lines connect counts from the same validation image. Black
center line and box represents mean ± SD. Difference between manual counts and
automated counts produced by the pixel-based workflow of StarDist was assess using
two-tailed paired T-tests. Significant differences are indicated by asterisks (*p≤0.05,
**p≤0.01, ***p≤0.001).
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Table 5: Performance of StarDist deep-learning model surpasses the performance of
a previous validated pixel-based method for HIV target cell segmentation
Cell Types

Total Counts*

% Difference
from Manual
Counts
% Change
from Manual
Counts

True Positives
(TP)

False Positive
(FP)

False Negative
(FN)
Sensitivity/
True Positive
Rate
(TPR)
Precision/
Positive
predictive
value (PPV)
False negative
rate
(FNR)
False
discovery rate
(FDR)

All
Cells

CD3+
Cells

CD4+
Cells

CCR5+
Cells

CD3+
CD4+
Cells

CD3+
CCR5+
Cells

CD4+
CCR5+
Cells

CD3+
CD4+
CCR5+
Cells

Manual

20037

1697

1843

1231

939

800

792

542

PixelBased

19736

1651

1726

1019

796

704

1013

422

StarDist

19956

1673

1866

1259

978

825

887

621

PixelBased

1.51%

2.75%

6.56%

18.84%

16.48%

12.77%

14.19%

24.90%

StarDist

0.41%

1.42%

1.24%

2.25%

4.07%

3.08%

11.32%

13.59%

PixelBased

-1.50%

-2.71%

-6.35%

-17.22%

-15.23%

-12.00%

15.28%

-22.14%

StarDist

-0.40%

-1.41%

1.25%

2.27%

4.15%

3.13%

11.99%

14.58%

PixelBased

18750

1546

1554

918

754

639

637

329

StarDist

19720

1609

1780

1185

903

788

780
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PixelBased

986

105

172

101

42

65

276

93

StarDist

236

64

86

74

75

37

107

92

PixelBased

1287

151

289

313

185

161

155

213

StarDist

317

88

63
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36

12

12

13

PixelBased

93.58%

91.10%

84.32%

74.57%

80.30%

79.88%

80.43%

60.70%

StarDist

98.42%

94.81%

96.58%

96.26%

96.17%

98.50%

98.48%

97.60%

PixelBased

95.00%

93.64%

90.03%

90.09%

94.72%

90.77%

69.77%

77.96%

StarDist

98.82%

96.17%

95.39%

94.12%

92.33%

95.52%

87.94%

85.19%

PixelBased

6.42%

8.90%

15.68%

25.43%

19.70%

20.13%

19.57%

39.30%

StarDist

1.58%

5.19%

3.42%

3.74%

3.83%

1.50%

1.52%

2.40%

PixelBased

5.00%

6.36%

9.97%

9.91%

5.28%

9.23%

30.23%

22.04%

StarDist

1.18%

3.83%

4.61%

5.88%

7.67%

4.48%

12.06%

14.81%

*Generated from 10 FOV images (600x600 µm) of foreskin tissue stained for CD3, CD4, CCR5, and nuclei.
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3.3.2

StarDist does not have issue with systematic overcounting or
undercounting in different tissue regions
The epidermis and dermis regions of the foreskin are very different in terms of

cell density and level of autofluorescence (Figure 1&2). To improve the accuracy of
automated cell segmentation, many pixel-based workflows process the epidermis and
dermis region of tissues using different image analysis parameters. However, even with
specialized image processing for different tissue regions, systematic undercounting and
overcounting can still occur. To determine if our StarDist model is also affected by
systematic counting errors in different tissue regions, we manually split the 10 validation
images described in section 3.3.1 into epidermis and dermis regions and determined the
total number of manual counts, automated counts from the pixel-based method, and
automated counts from StarDist for each of the regions. We compared the percent change
of automated counts generated using the pixel-based method and automated counts
generated using StarDist from manual counts in the epidermis or dermis to determine if
systematic overcounting or undercounting was occurring. Percent change was selected as
the metric used for assessment as it provided information on the directionality of
differences between automated counts and manual counts (Figure 6).
For full tissue sections (before splitting into separate tissue regions) the percent
change of StarDist counts from manual counts was within ± 5% for all cell types except
for CD4+CCR5+ cells (12.0%) and CD3+CD4+CCR5+ cells (14.6%). Automated
segmentation with the pixel-based workflow was less accurate when looking at full tissue
section counts as the percent change from manual counts was only with ±10% for total
cell count, CD3+ cell counts, and CD4+ cell counts. The percent change for all other cell
counts were outside of ±12% and specifically for CD3+CD4+CCR5+ cells at -22.1%.
Overall, the percent change of automated counts from manual counts in the epidermis
showed that both the pixel-based method and StarDist method were overcounting. This
was much more dramatic for the pixel-based method. There was a positive percent
change from manual counts for all cell types. In particular, the percent change from
manual counts was over +25% for CD4+ cells, CCR5+ cells, CD3+CD4+ cells,
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CD4+CCR5+ cells, and CD3+CD4+CCR5+ cells (Figure 6). Overcounting by the
StarDist model in the epidermis was very minimal. There was a positive percent change
for counts for all cell types except for CD3+ cells (-3.2%), however, all percent change
values were within ±10%. In the dermis, the pixel-based method displayed systematic
undercounting as counts for all cell types had a negative percent change from manual
counts. In particular, the percent change from manual counts for CD4+ cells, CCR5+
cells, CD3+CCR5+ cells, and CD3+CD4+CCR5+ cells were below -20%. The StarDist
model had a negative percent change from manual counts for cell counts for total cell
count, CD4+ cells, CCR5+ cells, CD3+CD4+ cells and CD3+CCR5+ cells but the
percent change values for all cell types except for CD4+CCR5+ cells (12.2%) and
CD3+CD4+CCR5+ cells (11.6%) were within ±10% (Figure 6). Overall, these results
show that our StarDist model does not have issue with systematic overcounting or
undercounting in different tissue regions.
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Figure 6: Automated cell segmentation using StarDist does not result in major
overcounting or undercounting in different tissue regions. Cell counting was
completed on 10 validation field-of-view images (600x600µm) randomly generated from
a set of 232 full foreskin tissue section scans stain for CD3, CD4, CCR5, and nuclei to
identify HIV susceptible cells in the tissue. The 10 validation images include both inner
foreskin and outer foreskin images. Cell segmentation was completed on the full field-ofview images before images were manually divided into the epidermis and dermis
sections. (A-C) Difference between automated counts and manual counts in (A) full
tissue, (B) epidermis, and (C) dermis is shown as percent change of automated counts
from manual counts. Percent difference of counts generated using a pixel-based approach
is represented by purple bars while percent difference of counts generated using StarDist
is represented by blue bars. Red dotted lines mark ±10% change of automated counts
from manual counts.
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3.3.3

Automated cell segmentation with StarDist is robust in areas
with high cell density or high autofluorescence.
Pixel-based approaches for automated cell segmentation often struggle in areas

with high cell density or high autofluorescence. Thresholding in areas with high cell
density can often result in cell merging or splitting. Collagen fibers found in the dermis of
foreskin tissue are highly autofluorescent and are often misidentified as cells with pixelbased cell segmentation methods. Due to the high prevalence of areas with densely
packed cells and autofluorescence in foreskin tissue, it is critical that automated cell
segmentation methods used to quantify HIV target cells are robust in these areas. While
deep-learning methods for automated cell segmentation are designed to be less affected
by noise, it was unclear if automated segmentation of HIV target cells using our custom
StarDist model would be more effective than a pixel-based approach in difficult tissue
regions with high cell density or high autofluorescence.
To compare the performance of our StarDist model with the performance of pixelbased approach in tissue regions with high cell density or high autofluorescence, we
created 4 image crops (70x70µm) containing areas with high cell density and 4 image
crops (70x70µm) containing areas with high levels of autofluorescence from each of the
10 validation images mentioned in section 3.3.1. This resulted in a total of 40 images
crop containing areas with high cell density and 40 image crops containing areas with
high levels of autofluorescence (Figure 7). High autofluorescence areas were
characterized by the abundance of autofluorescent collagen fibers (Figure 7A2). Each of
these image crops contained less than 30 cells and were meant to represent problematic
areas that would challenge conventional pixel-based automated cell segmentation. We
applied the StarDist model and pixel-based workflow on the image crops. Based on the
image crops with high cell density, we determined the total number of images where cell
merging or splitting occurred during the cell segmentation process for StarDist or the
pixel-based approach (Figure 7A3, B3, C3, D3). Based on the image crops with high
autofluorescence, we determined the total number of images where autofluorescent
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collagen fibers were misidentified as cells by StarDist or the pixel-based approach
(Figure 7A2, B2, C2, D2).
Cell merging and cell splitting occurred in ≥2 out of the 40 high cell density
images when processed by the pixel-based approach for any cell type. There were over
10/40 images where cell splitting or merging occurred for nuclei, CD3+ cells, CD4+
cells, and CCR5+ cells for the pixel-based approach. In general, the number of image
crops where cell merging occurred was 2 (CD4+CCR5+ cells) to 7 times (CD4+ cells)
more for the pixel-based approach compared to processing with StarDist. In fact, cell
merging and splitting only occurred in ≤6 images tested out of 40 for all cell types when
processed using StarDist. No cases of cell merging occurred for CD3+CD4+ cells or
CD3+CD4+CCR5+ cells and cell splitting was only seen for the segmentation of nuclei
when using StarDist to process the 40 high cell density image crops (Table 6). Cell
merging and cell splitting was most common for the segmentation of nuclei, likely due to
the high number of nuclei compared to the number for the other individual cell types.
Misidentification of autofluorescence as cells occurred ≥10 out of 40 high
autofluorescence image crops tested for all cell types except for CD4+CCR5+ cells and
CD3+CD4+CCR5+ cells when using the pixel-based approach for analysis. Conversely,
misidentification of autofluorescence as cells occurred in ≤5 out of 40 high
autofluorescence image crops when using StarDist for analysis. For both the pixel-based
approach and StarDist, misidentification of autofluorescence as cells was most prevalent
for CD3+ cell segmentation (35/40 image crops for pixel-based, 5/40 image crops for
StarDist) (Table 7). Overall, these results suggest that StarDist is less likely to have
problems with cell merging/splitting and misidentification of autofluorescence as cells.
Automated cell segmentation with StarDist appears to robust in areas that would
normally challenge pixel-based automated cell segmentation workflows (Figure 7).
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Figure 7: Comparison of automated cell segmentation using StarDist and a pixelbased workflow in tissue regions with high cell density or high autofluorescence.
Four image crops (70x70µm) representing areas of high cell density and four image crops
representing areas with autofluorescence was generated from each of the 10 “validation”
field-of-view images (600x600µm) generated from full foreskin tissue scans stained for
CD3, CD4, CCR5 and nuclei (imaged at 200x total magnification). Cell segmentation
was completed on the full field-of-view images before cropping. Less cell
merging/splitting and misidentification of autofluorescence as cells was seen with the
StarDist approach. Images shown in figure represent: (A1-A3) Unprocessed image of
nuclei staining, (B1-B3) manual tracing of nuclei representing the ground truth, (C1-C3)
automated segmentation using a pixel-based approach, (D1-D3) automated segmentation
using StarDist. (A1, B1, C1, D1) Processing of validation field-of-view without cropping.
(A2, B2, C2, D2) Processing of a tissue region with high autofluorescence. (A3, B3, C3,
D3) Processing of a tissue region with high cell density. Yellow arrows point to
autofluorescent collagen fibers while cyan arrows point to tightly packed cells.
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Table 6: StarDist is less likely to have issues with cell merging, cell splitting, or
misidentification of autofluorescence as cells in tissue regions with high cell density
or high autofluorescence when compared to automated pixel-based cell
segmentation
Cell Types
CD3+
CCR5+
Cells

CD4+
CCR5+
Cells

CD3+
CD4+
CCR5+
Cells

All
Cells

CD3+
Cells

CD4+
Cells

CCR5+
Cells

CD3+
CD4+
Cells

Pixel-Based

32

13

14

17

5

8

8

2

StarDist

6

6

2

4

0

1

2

0

Pixel-Based

22

12

10

11

2

2

3

2

StarDist
Misidentification
of Autofluorescence as
Cells **

5

0

0

0

0

0

0

0

Pixel-Based

27

35

16

15

11

14

7

2

Cell Merging*

Cell Splitting*

2
5
3
3
3
2
3
StarDist
*Number of images (out of 40 images of tissue regions with high cell density) where cells were
inaccurately merged or split during automated cell segmentation.
**Number of images (out of 40 images of tissue regions with high abundance of autofluorescent
collagen fibers) where autofluorescence was misidentified as cells.

0

53

3.3.4

Accuracy of custom StarDist model rapidly improves with
additional training images
Manual annotation of training images is by far the most time-consuming step of

the training process of deep-learning models, and it can be hard to determine the optimal
balance between improvements in model accuracy and time-investment for training. In
this section, we show the improvement of our StarDist model in segmentation of nuclei
(all cells), CD3+ cells, CD4+CCR5+ cells and CD3+CD4+CCR5+ cells after training
with 10, 20, 30, and 40 images (Figure 8). The cell types that were chosen as points of
focus for this analysis were selected based on their relevance to HIV susceptibility. Cells
that are CD3 positive represent T cells, cells that are positive for CD4/CCR5 represent
cells that HIV can attach to for entry, and cells that are positive for CD3/CD4/CCR5
represent CD4+CCR5+ T cells, which are the main reservoir for productive HIV
infection in sexual transmission. Furthermore, the cell types selected are also relevant in
terms of the number of image channels that are used as input. The segmentation of CD3+
cells, CD4+CCR5+ cells, and CD3+CD4+CCR5+ cells require 2, 3, and 4 image
channels respectively as input for detection. Pooled cell counts were generated using the
10 validation images described in section 3.3.1 as input and percent difference from
manual counts was used as a metric to measure accuracy. Overall, these results can serve
as a guide for the training of new custom models to quantify other types of immune cells
in genital mucosal tissue.
As expected, the percent difference of automated counts generated by StarDist
from manual counts for all cell, CD3+ cells, CD4+CCR5+ cells and CD3+CD4+CCR5+
cells decreased with each of addition of 10 annotated images for training. The percent
difference from manual counts for CD3+ cell counts, CD4+CCR5+ cell counts, and
CD3+CD4+CCR5+ cell counts was reduced by 65-75%, 30-55%, 30-45% respectively
with every additional 10 images used for training (Figure 8D). All versions of the
StarDist model, except for the model trained with only 10 images, was the most accurate
in segmentation nuclei (all cells), followed by segmentation of CD3+ cell, CD4+CCR5+
cells, and CD3+CD4+CCR5+ cells (ordered by lowest percent difference from manual
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counts to highest percent difference from manual counts). The percent difference of
automated StarDist counts from manual counts was below 10% for all cells (all nuclei)
after training with 10 images and below 10% for CD3+ cells after training with 20
images. While automated segmentation of CD4+CCR5+ cells and CD3+CD4+CCR5+
cells did not manage to achieve a percent difference less than 10% after training with 40
images, the percent difference was very close to 10% at 11.32% and 13.59% respectively
(Figure 8D).
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Figure 8: Training images rapidly improve the accuracy of a custom StarDist model
used for the quantification of HIV target cells in foreskin tissue. (A-C) Workflow of
annotating foreskin tissue stained for CD3, CD4, CCR5, and nuclei for StarDist model
training. (A) Raw image of nuclei staining. (B1-B2) Manual cell counting using the Cell
Counter plugin for Fiji. (C) Tracing of cells in the LabKit plugin for Fiji to produce
annotated images for training. (D) Percent difference of automated counts generated by
StarDist from manual counts for nuclei (all cells), CD3+ cells, CD4+CCR5+ cells, and
CD3+CD4+CCR5+ cells after training with 10 images, 20 images, 30 images, and 40
images. Counting was completed on 10 validation field-of-view images (600x600µm)
randomly generated from a set of 232 full foreskin tissue section scans stain for CD3,
CD4, CCR5, and nuclei to identify HIV susceptible cells in the tissue.
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3.4 Discussion
In this chapter we described the development and validation of a deep-learning
approach to quantify HIV target cells in foreskin tissues. Using the Snakemake workflow
management system and the StarDist plugin for Fiji, we trained a custom StarDist deeplearning model that can be used to identify HIV target cells in multi-channel
immunofluorescent microscopy images of foreskin tissue (113,125,129). The accuracy of
this deep-learning model was compared to manual counting and a conventional
automated cell segmentation algorithm which utilizes a pixel-based approach (126). The
reliability of the deep-learning model was also further tested in tissue regions with high
cell density or high autofluorescence.
Most new HIV infections worldwide are still acquired via sexual transmission. In
men, the availability of target cells in the foreskin is a critical determinant of HIV
susceptibility in men during sex (38,41,54,91). Immunofluorescent microscopy is an
excellent tool for understanding the spatial distribution of immune cells in genital
mucosal tissues, however, cell segmentation in IF microscopy images can be difficult.
Previous studies have relied on manual counting to quantify cells of interest; however,
this approach is very time consuming and is vulnerable to bias due to the subjective
nature of manual counting. Overall, manual counting is not feasible especially when full
tissue section scans from large study cohorts need to be analyzed. Studies that use an
automated approach for cell segmentation in immunofluorescent microscopy images
often use a pixel-based workflow that relies on thresholding to identify positively stained
cells (120,130). However, the reliability of this method is poor in regions with high cell
density and high autofluorescence.
To address the issues related to automated immune cell segmentation in IF
microscopy images of genital mucosal tissue, we developed and validated a deep-learning
approach to quantify HIV target cells in the foreskin (113,125). This approach can
replace conventional pixel-based methods for immune cell quantification and can be
easily adapted to accommodate the detection of a wide variety of immune cell subsets in

57

different types of genital mucosal tissue. Our approach utilizes multi-channel IF
microscopy images as input and enable the detection of multiple cell types (based on
combination of marker staining) simultaneously. We decided to use StarDist and its
plugin for Fiji as the backbone for the development of our deep-learning model because
of its accessibility (113,125). StarDist is open source and use of StarDist models can
easily be incorporated into existing image analysis workflows. Plugins that allow StarDist
models to be run without any programming knowledge requirements are available for
popular open-source software such as ImageJ/Fiji, Napari, QuPath, Icy, and KNIME
(113,115,131,132). Results from utilizing StarDist models are also highly reproducible
since trained StarDist models and training datasets can be easily shared.
The performance of our StarDist model against manual counting and automated
segmentation using a conventional pixel-based approach using 10 validation images.
Based on our validation, our custom StarDist model exceeded conventional pixel-based
cell segmentation in performance metrics including percent difference from manual
counts, sensitivity, precision, false negative rate, and false discovery rate (Table 5). Most
notably, our custom StarDist model achieved over 94% sensitivity and over 85%
precision for all cell types we examined. Automated counts with StarDist were also
highly comparable to manual counts. There was no significant difference between
StarDist counts and manual counts for all cell types examined for the 10 validation
images (Figure 5). The percent difference of StarDist counts from manual counts was
also less than 5% for all cell types except for CD4+CCR5+ cells (11.32%) and
CD3+CD4+CCR5+ cells (13.59%). However, the percent difference of counts for these
cell types are likely to decrease with more training. These cell types were the rarest
among all cell types we examined, thus fewer instances were available for training
compared to other cell types (Table 5). Detection of these cell types is also more
complex as image information from 3 channels are used to detect CD4+CCR5+ cells and
image information from 4 channels are used to detect CD3+CD4+CCR5+ cells. Cell
detection using our StarDist model also appears to be robust in challenging tissue areas
with high cell density or high levels of autofluorescence (Figure 7). Performance of
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conventional automated cell segmentation can struggle in both the epidermis and dermis
region of foreskin tissue for different reasons. In the epidermis, thresholding can be
difficult due to high cell density. In the dermis, thresholding can be difficult due to high
abundance of autofluorescent collagen fibers. In contrast to conventional automated cell
segmentation that relies on thresholding, StarDist did not systematically overcount or
undercount in the epidermis or dermis (Figure 6). StarDist also managed to detect cells
with high accuracy in isolated cases of high cell density or high autofluorescence (Table
6). Based on these results, we conclude that the performance of our StarDist model is
comparable to manual counting and StarDist is a suitable replacement for conventional
pixel-based approaches for HIV target cell quantification.
A limitation of our custom StarDist model is that the images used for the training
and validation were all acquired using the same microscope with the same imaging
settings. The differences resulting from acquiring images with different microscopes may
impact the accuracy of our model. While it might be possible to rescale images and to
normalize the properties of images acquire from different microscopes, it is possible that
our StarDist model will not perform reliably using images from other microscopes.
Furthermore, our StarDist model is trained using foreskin tissue stained for CD3, CD4,
CCR5, and nuclei. It cannot be reliably used to analyze foreskin tissues stained for
different markers. The use of this algorithm with other tissue types such as cervical tissue
has also not been validated. However, an easy solution for all these limitations is training
with new images. New StarDist models can quickly be trained using our Snakemake
framework (113,125,129).
An advantage of the StarDist approach for cell segmentation is that star-convex
polygons are very good at identifying blob-like objects like nuclei or T cells. However,
star-convex polygons are also bad at fully approximate the irregular shape of sprawling
cells such as Langerhans cells. Deep-learning methods based on other shape
approximation strategies might be needed to accurately segment irregularly shaped
immune cells (133). Recent work by Mandal et al. described using planar parametric
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spline curves for cell segmentation in a method called SplineDist (134). This method was
shown to be capable of being incorporated into the StarDist architecture to accurately
capture non-star-convex objects. Discrete cell segmentation methods, including StarDist,
are also limited in the sense that positive cell surface marker staining that is unassociated
with nuclei is unaccounted for in the segmentation process. The appendages of sprawling
HIV target cells such as Langerhans cells and dendritic cells can often span through
multiple tissue sections, resulting in cell membrane area that is positively stained for CD4
and CCR5 but unassociated with nuclei. Not accounting for these areas ignores a large
amount of tissue area that HIV virions can use for cell entry. While pixel-based methods
for image analysis are problematic for discrete cell segmentation, they are good for
measuring the total amount of tissue area that is positively stained for a particular marker.
Thus, pairing StarDist HIV target cell counting results with results from pixel-based
quantification of CD4+CCR5+ tissue area could be beneficial in terms of gaining a more
holistic understanding of HIV susceptibility in foreskin tissue.
To our knowledge, this study is the first to describe deep-learning methods for the
identification of HIV target cells in multi-channel IF microscopy images of genital
mucosal tissue. Previous studies have extensively described deep-learning methods for
segmentation of CD3+ cells but these methods are mostly on histology images (135–
138). Among the existing studies that use deep learning to segment cells in IF
microscopy images, the vast majority are exclusively focused on nuclei segmentation.
Existing methods for deep-learning cell segmentation in IF microscopy images are not
designed to enable simultaneous quantification of multiple cell types. This limits
understanding of both the distribution and composition of immune cells. Implementation
and reproducibility of these models compared to StarDist are also more limited as they
require a higher-level understanding of convolutional neural networks and software
packages related to neural network construction (139,140).
Manual annotation of training images is one of the most time-consuming steps for
the development of any supervised deep-learning models of cell segmentation. To work
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around the problem of generating training images, recent studies have focused on
developing generalist methods for cell segmentation that does not require new training
data. These models were designed for nuclei segmentation; however, it is possible that
these approaches can be adapted to work with T cells and other rounded cells have
defined cell borders (139,141–143). Other previous attempts at improving the ease of
adopting custom deep learning methods includes the creation of shared repositories of
training sets with various tissue types and trained models. However, these repositories
mainly contain IF images of nuclei or histology images. Improving the diversity of
training images in these repositories would greatly improve the adoptability of deeplearning methods for cell segmentation (144–147).
In conclusion, in this chapter we showed that deep learning is an accurate and
time saving approach that can be used to analyze immune cell composition in full
mucosal tissue section scans. We trained and validated a custom StarDist model that
produces highly accurate counts of HIV target cells in foreskin tissue. This model is
robust in regions of high cell density and autofluorescence. Overall, this model can be
easily applied and incorporated into existing ImageJ workflows which makes it an
appropriate replacement for conventional pixel-based methods for automated HIV target
cell segmentation.
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Chapter 4

4

Effect of antimicrobial treatments on the penile
microbiome, inflammation, and HIV target cells

4.1 Introduction
While many effective strategies are now available for HIV prevention, the
reduction in the annual number of new HIV infections among adults has stalled since
2016 (1,13). Between 2010 and 2020, the total of new infection globally has only
declined by 31%, which is far short of the 2020 UNAIDS target of 75%. Implementation
of existing HIV prevention strategies has proven to be inefficient, and many countries
have yet to sufficiently implement effective prevention measures for individuals who are
most at risk of infection (18,148–150). Thus, a rework of current HIV prevention
strategies and new tools for HIV prevention could be needed to increase the current pace
of reducing new HIV infections globally.
Circumcision can reduce a heterosexual man’s risk of acquiring HIV by up to
60% (14–16). However, many men at high risk of HIV acquisition still choose to remain
uncircumcised and the biological mechanisms behind how circumcision modifies HIV
risk is not completely understood. The abundance of certain species of anaerobic bacteria
which are reduced by circumcision, was previously associated with HIV seroconversion,
penile inflammation, and the abundance of HIV target cells in the foreskin in
uncircumcised men (64,73,75,76). It is possible that these penile bacteria may be causing
local inflammation which results in the recruitment of HIV target cells in the foreskin
(31). If this is the case, modification of the penile microbiome in uncircumcised men
using antimicrobial agents may represent a novel method of reducing the HIV
susceptibility of men who choose to remain uncircumcised. However, it is not known if
or which antimicrobial agents can optimally reduce penile anaerobes associated with HIV
risk and if the reduction in the anaerobes will reduce foreskin inflammation and HIV
susceptibility. In this chapter, we present select results from an open-label randomized
controlled trial which examined the effect of commonly available antibacterial agents on
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the foreskin microbiome, inflammation, and HIV susceptibility in Ugandan men (77).
Specifically, men were either circumcised immediately without delay (control group) or
asked to use topical clindamycin, topical metronidazole, topical hydrogen peroxide, or
oral tinidazole for 4 weeks prior to circumcision. Using foreskin tissue collected at time
of circumcision we compared the foreskin HIV target cell abundance between treatment
group and control group men. We also correlated the abundance of HIV target cells in the
foreskin with the abundance of BASIC species bacteria and soluble inflammatory
markers in the coronal sulcus at time of circumcision. Detailed description of the
randomized controlled trial can be found in chapter 2.

4.2 Methods
4.2.1

Quantification of HIV target cell availability using
immunofluorescence microscopy
HIV target cells were quantified in IF microscopy images of foreskin tissue using

(1) the automated deep-learning cell segmentation algorithm described in Chapter 3; (2)
an automated pixel-based algorithm, that measures the total tissue area positive for both
CD4 and CCR5 (as opposed to the pixel-based cell segmentation algorithm described in
Chapter 3). The deep-learning cell segmentation algorithm was used to measure the
number of HIV target cells per unit area of foreskin tissue. The pixel-based algorithm
was used to quantify the total tissue area that is positive for both CD4 and CCR5. While
the pixel-based algorithm is a simplified method for HIV target cell quantification, it
complements the deep-learning algorithm since irregularly shaped target cells that are
not captured effectively by discrete cell segmentation methods can be accounted for
using this method (125).
We focused our image analysis only on the tissue area that was within 300µm of
the apical surface of the epithelium (Figure 9). This was done as the total amount of
dermis tissue in tissue sections varied greatly between study participants. The threshold
of 300µm from the apical surface of the epithelium was selected as this area contained
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the vast majority of HIV target cells in the tissue sections and would be most relevant for
comparing HIV susceptibility between treatment groups (Figure 9).

Figure 9: Tissue area used for HIV target cell quantification in immunofluorescent
microscopy images of foreskin tissue. Full tissue section scans of foreskin tissue stained
for CD3, CD4, CCR5, and nuclei were captured at 200x total magnification. The area
within 300µm of the apical edge of the epidermis in each image was manually cropped
out and saved for automated image analysis. HIV target cells in the 300µm region were
quantified using a deep-learning cell segmentation algorithm and a pixel-based algorithm
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was applied to determine the percent coverage of tissue area susceptible for HIV entry
(CD4+CCR5+ tissue area) in the 300µm region.

4.2.2

Pixel-based quantification of HIV target cells by determine
the percent coverage of tissue area

The workflow for this algorithm is built on image processing functions in the Fiji
distribution of ImageJ2 (version 2.6.0) and the Adaptive Thresholding plugin (version
2019.06.24) for ImageJ (113,127). This approach for quantifying HIV target cells has
been published by our group (126).
(1) The total size of the tissue section was measured by applying the “Analyze Particles”
function in Fiji with the parameters for “Circularity” set from 0.00 to 1.00, “Size” set
from 0 to infinity, and options for “Display Results” and “Summarize” checked.
Tissue section size measurement was completed on composite images of the tissue
section scans with contains all channels merged (Figure 10A).
(2) CD4 and CCR5 channel images undergo thresholding to eliminate background noise
and isolate positive staining signal (Figure 10B1, 10B2). The CD4 and CCR5
channel images were first converted to 8-bit format and then the “Adaptive
Thresholding” plugin is used with the parameters for “Block Size” and “Subtraction
Value” set at 100 and -5 respectively for CD4 and 100 and -40 respectively for
CCR5 (Figure 10C1, 10C2).
(3) Positive staining for CCR5 is outlined and saved as “Regions of Interest” files using
the “Analyze Particles” function in ImageJ with the parameters for “Circularity” set
from 0.00 to 1.00, “Size” set from 0 to infinity, and options for “Overlay” and “Add
to Manager” checked.
(4) To determine the tissue area that is positive for both CD4 and CCR5, the CCR5
“Region of Interest” files were overlayed on top of a corresponding CD4 channel
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image and then the “Clear Outside” function in Fiji is applied to eliminate any CD4
positive staining that is not within a CCR5 “Region of Interest” outline (Figure
10D1, 10D2). The remaining CD4 positive staining represents tissue area that is
positive for both CD4 and CCR5 (Figure 10E).
(5) The total area of this CD4 and CCR5 positive staining was measured by applying the
“Analyze Particles” function in ImageJ with the parameters for “Circularity” set
from 0.00 to 1.00, “Size” set from 0 to infinity, and options for “Display Results”
and “Summarize” checked.
(6) This area was divided by the total tissue section area to determine the percent signal
coverage for CD4 and CCR5 for each tissue section.
The validity of this algorithm was assessed by comparison to manual assessment of
CD4/CCR5 expression levels. Five randomly selected images (600µm by 600µm) were
ranked by visual inspection from lowest to highest percent signal coverage for CD4 and
CCR5. The percent signal coverage for CD4 and CCR5 were calculated by the pixelbased algorithm, and these numbers were used to generate rankings, which were
compared to manual ranking.
Pre-written script for batch processing for the pixel-based quantification algorithm
described above has been made available in the public domain
(https://github.com/prodgerlab/pixel-based-quantification).
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Figure 10: Overview of pixel-based approach for the quantification of tissue area
available for HIV entry (CD4+CCR5+ area) in foreskin tissue section scans.
Analysis was completed using only the tissue area that was within 300µm of the apical
surface of the epidermis of adult foreskin tissue (both inner and outer foreskin) stained
for CD3, CD4, CCR5, and nuclei and imaged at 200x total magnification. (A)
Representative image of foreskin tissue stained for the identification of HIV target cells.
Image is a composite representing positive staining from all channels merged together.
Raw, unprocessed staining for (B1) CCR5 and (B2) CD4 in the representative image.
Binary image of (C1) CCR5+ staining and (C2) CD4+ staining after adaptive
thresholding. (D1) Isolation and selection of CCR5+ staining and (D2) overlay of CCR5+
staining on CD4+ staining. (E) Elimination of CD4+ positive staining that does not
overlap with CCR5+ positive staining to determine area that is positively stained for both
CD4 and CCR5. Tissue area available for HIV entry is quantified by determine the
percent coverage of CD4+CCR5+ staining over the tissue section.
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4.2.3

Statistical analysis
Statistical analysis was completed using Prism v9 (GraphPad Software). The

impact of antimicrobial agents on the density of HIV target cells in the foreskin based on
immunofluorescent microscopy was assessed by comparing each antimicrobial
intervention group with the untreated control group using a two-tailed Mann-Whitney
tests. The difference in HIV target cell density between the inner foreskin and outer
foreskin in all participants will be compared using a Wilcoxon matched pairs signed rank
tests. The relationship between the penile absolute abundance of bacterial species of
interest (i.e. bacterial species previously associated with HIV seroconversion,
inflammation, and HIV target cell recruitment to the inner foreskin) and the density of
HIV target cells in the inner foreskin will be determined as follows. First, participants
will be organized from lowest to highest penile abundance of BASIC species and control
taxa at the time of circumcision. Next the HIV target cell density of participants with no
detectable amounts of BASIC species will be compared with the HIV target cell density
of participants in the top quartile in terms of absolute abundance of BASIC species and
control taxa using a Kruskal-Wallis test followed by a Dunn’s multiple comparisons test.
Correlation between penile levels of inflammatory cytokines/chemokines and the density
of HIV target cells in the inner foreskin at the time of circumcision will be assessed with
a simple linear regression.
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4.3 Results
4.3.1

Effect of antimicrobial treatments on the abundance of penile
bacteria
Penile microbiome data collection and bacteria swab sample processing was

completed by study collaborators at George Washington University. Analysis was
completed only for men who had available swab samples at all timepoints and were not
lost to follow-up: clindamycin group (n=22), hydrogen peroxide group (n=25),
metronidazole group (n=22), tinidazole group (n=23) (Figure 11).
Although not a part of this thesis, the effect of treatment on penile bacteria is
presented here for context.
Both the total bacteria absolute abundance and pooled BASIC species absolute
abundance was significantly reduced (p<0.05) by topical antimicrobial treatments (topical
clindamycin, topical hydrogen peroxide, topical metronidazole) after 1-week and 4weeks of treatment while the pooled absolute abundance of control taxa bacteria was
either not significant changed (p>0.05) or was significantly increased (p<0.05) after 1- or
4- weeks of treatment (Figure 11). For all treatments, the median total bacteria absolute
abundance and median of pooled BASIC species absolute abundance was lower at the 1week timepoint when compared to the 4-week timepoint. The most reduction in total
bacteria absolute abundance and pooled BASIC species absolute abundance after 1 week
of treatment was seen in the topical clindamycin group and then followed by the topical
metronidazole group (Figure 11).
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Figure 11: Topical antimicrobial treatments reduce total bacteria absolute
abundance and BASIC species absolute abundance but not control taxa absolute
abundance. The penile microbiome of study participants was characterized via amplicon
sequencing and qPCR of the V3V4 hypervariable regions of the 16S rRNA gene using
coronal sulcus swabs collected at baseline, 1-week of treatment and at the time of
circumcision (4-weeks of treatment). Analysis was completed only for men who had
available swab samples at all timepoints: clindamycin group (n=22), hydrogen peroxide
group (n=25), metronidazole group (n=22), tinidazole group (n=23). Total bacteria
absolute abundance and BASIC species absolute abundance were significantly lower
(p≤0.05) at 1- and 4-weeks of treatment when compared to baseline for all topical
antimicrobial treatment groups. Control taxa absolute abundance was not significantly
different (p>0.05) or was significantly increased (p≤0.05) after any treatment for 1-week
or 4-weeks. Data shown is log10 change of absolute bacteria abundance after 1-week
(black triangle) or 4-weeks (pink triangle) of treatment. Solid black line and box
represents median and interquartile range respectively. Difference in absolute bacterial
abundance between 1-week of treatment and baseline and 4-weeks of treatment and
baseline was assessed using Wilcoxon matched-pairs signed rank tests. Significant
differences (p≤0.05) are represented by asterisks (*p≤0.05, **p≤0.01, ***p≤0.001,
****p≤0.0001).
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4.3.2

Effect of antimicrobial treatments on the density of HIV target
cells in the foreskin
We focused our analysis on CD3+ cells (representing all T cells),

CD3+CD4+CCR5+ cells (representing CD4+CCR5+ T cells), and CD3-CD4+CCR5+
cells (representing HIV target cells that are not T cells, this includes cells such as
Langerhans cells, dendritic cells, and macrophages). The pixel-based algorithm was used
to complement the cell segmentation algorithm. Using the pixel-based algorithm, we
determined the percent coverage of total tissue area that was susceptible to HIV entry.
Based on this analysis strategy, we found that antimicrobial treatments reduced
the abundance of HIV target cells in the foreskin, and this effect was limited to the inner
foreskin (consistent with being caused by bacteria in the sub-preputial space) (Figure
12). The inner foreskin samples of participants in the topical clindamycin group and the
topical metronidazole group had significantly lower density of CD3+ cells (T cells),
CD3+CD4+CCR5+ cells (CD4+CCR5+ T cells), and CD3-CD4+CCR5+ cells (non-T
cell HIV target cells) when compared to inner foreskin samples from men in the control
group (p<0.05). The percent coverage of CD4+CCR5+ area was also significantly lower
in the inner foreskin samples from men in the clindamycin and metronidazole group
when compared to control. The only topical antimicrobial treatments that had a
significant effect on HIV target cells in the foreskin were clindamycin and metronidazole.
The CD3+ cell density, CD3+CD4+CCR5+ cell density, CD3-CD4+CCR5+ cell density,
and percent coverage of CD4+CCR5+ tissue area in the inner foreskin samples from the
topical hydrogen peroxide group were not significantly different from those in the control
group (Figure 12A1, B1, C1, D1). Interesting, inner foreskin samples from men in the
oral tinidazole were lower (p<0.05) in the density of T cells and T cell subsets (CD3+
cells, CD3+CD4+CCR5+ cells) when compared to control. However, CD3- HIV target
cell density (CD3-CD4+CCR5+ cells) and percent coverage of CD4+CCR5+ tissue area
were not significantly different when compared to control (p>0.05) (Figure 12A1, B1,
C1, D1).
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There was no significant difference in CD3+ cell density (T cells),
CD3+CD4+CCR5+ cell density (CD4+CCR5+ T cells), CD3-CD4+CCR5+ cell density
(CD3- HIV target cells) and the percent coverage of CD4+CCR5+ tissue area between
any of the treatment groups and the control group in the outer foreskin (Figure 12A2, B2,
C2, D2).
We did not find a significant difference in the proportion of CD3+CD4+ cells,
CD3+CCR5+ cells, and CD3+CD4+CCR5+ cells in the inner foreskin tissue of the
various treatment groups. Among all participants, CD3+CD4+ cell accounted for an
average of 58.4% of all CD3+ cells, CD3+CCR5+ cells accounted for an average of
41.3% of all CD3+ cells, and CD3+CD4+CCR5+ cells accounted for an average of
33.1% of all CD3+ cells (Table 7).
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Figure 12: Effect of antimicrobial treatments on the abundance of HIV target cells
in the foreskin. Foreskin tissue collected at time of circumcision from the randomized
controlled trial were snap-frozen, cryosectioned at 8µm, and stained for CD3, CD4,
CCR5, and nuclei for the identification of HIV target cells by immunofluorescent
microscopy. Stained foreskin tissue sections were imaged at 200x total magnification and
the tissue area within 300µm of the apical surface of the epidermis was analyzed using a
deep-learning cell segmentation algorithm to determine the density of HIV target cells
and an automated pixel-based algorithm to determine the percent coverage of HIV
susceptible tissue area (CD4+CCR5+ area). Inner foreskin from men in the topical
clindamycin and topical metronidazole groups had lower CD3+ cell density,
CD3+CD4+CCR5+ cell density, CD3-CD4+CCR5+ cell density, and percent coverage of
CD4+CCR5+ area when compared to those from control group men. Inner foreskin from
men in the oral tinidazole group also had lower CD3+ cell density and
CD3+CD4+CCR5+ cell density when compared to those from control group men.
Results are presented as median with interquartile range (black line and box
respectively). (A1-A2) CD3+ cell density, (B1-B2) CD3+CD4+CCR5+ cell density, (C1C2) CD3-CD4+CCR5+ cell density, and (D1-D2) % coverage of CD4+CCR5+ tissue
area in (A1, B1, C1, D1) inner foreskin and (A2, B2, C2, D2) outer foreskin samples.
Difference in cell density or percent coverage of CD4+CCR5+ area between treatment
groups and control group was assessed using two-tailed Mann-Whitney tests. Significant
differences (p≤0.05) are represented by asterisks (*p≤0.05, **p≤0.01, ***p≤0.001).
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Table 7: Proportion of CD3+ cell subsets in the inner foreskin of study participants
Proportion of CD3+ Cell Subsets*
CD3+CD4+

CD3+CCR5+

CD3+CD4+CCR5+

Cells

Cells

Cells

Control

49.9%

40.8%

29.3%

Topical

51.1%

41.2%

35.4%

60.8%

42.5%

30.2%

63.9%

41.0%

36.2%

Oral Tinidazole

63.5%

40.8%

34.8%

All Participants

58.4%

41.3%

33.1%

Clindamycin
Topical Hydrogen
Peroxide
Topical
Metronidazole

Note: CD3+ cell subset proportions are displayed as mean percentages. Differences in
CD3+ cell subset proportions between groups were evaluated using a Kruskal-Wallis
test followed by a Dunn’s multiple comparisons test. No significant differences were
found (p>0.05).
*Proportion of CD3+ cell subset out of all CD3+ cells.
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4.3.3

HIV target cell density is higher in the inner foreskin.
Evidence from previous studies have shown that the foreskin is enriched in HIV

susceptible CD4 T cell subsets such as Th17 cells cell compared to peripheral blood and
evidence suggests that the inner foreskin is more susceptible to HIV acquisition when
compared to the outer foreskin (28,30,32). Several studies have also compared the
composition of immune cells between the inner and outer foreskin and found that the
inner foreskin had both an increased density of CD4+ T cells and increased levels of
inflammatory cytokines (28–30). This evidence supports the idea that the anaerobic
conditions of the sub-preputial space (space between inner foreskin and glans in nonerect penis) is conducive to the generation of pro-inflammatory environment that
contributed to increased susceptibility to HIV infection.
We sought to examine if the difference in HIV target cell density in inner and
outer foreskin samples from participants in our randomized controlled trial would align
with these previous findings. To do this we compared the percent coverage of HIV
susceptible tissue area and the density of HIV target cells (determined from automated
analysis of immunofluorescent microscopy images) between the inner foreskin and outer
foreskin samples from all participants in the trial. From our analysis we found that CD3+
cell density (T cells), CD3+CD4+CCR5+ cell density (CD4+CCR5+ T cells), CD3CD4+CCR5+ cell density (CD3- HIV target cells), and the percent coverage of
CD4+CCR5+ tissue area were all significantly higher in the inner foreskin (p<0.01)
(Figure 13).
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Figure 13: Higher abundance of HIV target cells in found in the inner foreskin.
Foreskin tissue collected at time of circumcision from the randomized controlled trial
were snap-frozen, cryosectioned at 8µm, and stained for CD3, CD4, CCR5, and nuclei
for the identification of HIV target cells by immunofluorescent microscopy. Stained
foreskin tissue sections were imaged at 200x total magnification and the tissue area
within 300µm of the apical surface of the epidermis was analyzed using a deep-learning
cell segmentation algorithm to determine the density of HIV target cells and an
automated pixel-based algorithm to determine the percent coverage of HIV susceptible
tissue area (CD4+CCR5+ area). Comparisons revealed that (A) CD3+ cells density, (B)
CD3+CD4+CCR5+ cell density, (C) CD3-CD4+CCR5+ cell density, and (D) percent
coverage of CD4+CCR5+ tissue area were all higher in the inner foreskin. Results are
presented as median with interquartile range (black line and box respectively). Difference
in cell density or percent coverage of CD4+CCR5+ area between inner foreskin and outer
foreskin samples were assessed using Wilcoxon match-pairs signed rank tests. Significant
differences (p≤0.05) are represented by asterisks (**p≤0.01, ***p≤0.001).
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4.3.4

Soluble inflammatory molecules correlate with HIV target
cells density
One way that anaerobic bacteria could modulate HIV susceptibility is by causing

local inflammation in the inner foreskin which subsequently result in increased
abundance of immune cells including HIV susceptible CD4+ T cells. Based on this idea,
anaerobic bacteria previously associated with HIV risk would interact with the epithelial
cells and innate immune system of the foreskin mucosa and promote the release of
soluble mediators of inflammation in the foreskin.
Unpublished analysis performed by our collaborators have shown that the
abundance of soluble inflammatory molecules including soluble E-Cadherin, IL-1β, IL-8,
and Resistin were reduced by topical clindamycin and metronidazole treatment. The
results in section 4.3.2 of this thesis have also shown that the availability of HIV target
cells in the inner foreskin is significantly lower in men in the topical clindamycin, topical
metronidazole, and oral tinidazole groups (Figures 12). However, it is unclear if these
observations are related. To answer this question, we correlated the levels of soluble
inflammatory molecules in coronal sulcus swabs collected at the time of circumcision
with CD3+ cell density, CD3+CD4+CCR5+ cell density, CD3-CD4+CCR5+ cell density,
and the percent coverage of CD4+CCR5+ tissue area in the inner foreskin (Figures 1417). Based on our analysis, we found that the levels of 4 out of 9 inflammatory molecules
that we examined were positively correlated with the density of CD3+ cells,
CD3+CD4+CCR5+ cells and CD3-CD4+CCR5+ cells in the inner foreskin (p<0.01).
These 4 molecules include soluble E-cadherin, IL-1β, IL-8, and Resistin (Figures 14-16).
Of note, unpublished results from our collaborators have also shown that the
reduction in the levels of only these 4 molecules from baseline to time of circumcision
were associated with the reduction in total bacterial abundance and BASIC bacteria
abundance. Interestingly, we did not find the percent coverage of CD4+CCR5+ tissue
area in the inner foreskin to be significantly correlated with levels of any of the 9
inflammatory molecules we measured despite seeing a correlation between
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CD3+CD4+CCR5+ cell density and CD3-CD4+CCR5+ cell density with inflammatory
molecule levels (Figures 15-17). The levels of IL-1α, MIP-1, MMP-9, TIMP1 and VEGF
did not appear to be directly correlated to the abundance of HIV target cells in the inner
foreskin (p>0.05).
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Figure 14: Inner foreskin CD3+ cell density is correlated with soluble inflammatory
mediator levels in the coronal sulcus. Foreskin tissue collected from the randomized
controlled trial were cryosectioned at 8µm and stained for CD3, CD4, CCR5, and nuclei
for immunofluorescent microscopy analysis. Tiled full tissue sections scans were
captured at 200x total magnification and an deep-learning cell segmentation algorithm
was used to quantify CD3+ cells within 300µm of the apical surface of the epidermis in
each image. Soluble inflammatory mediator levels in coronal sulcus swabs collected
immediately before circumcision were measured using a chemiluminescent multiplex
ELISA assay. Levels of soluble E-Cadherin, IL-1β, IL-8 and Resistin were positively
correlated with CD3+ cell density (p<0.01). Trend lines represent simple linear
regressions. Significant correlations are indicated by red trendlines and red p-values
(p<0.05).
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Figure 15: Inner foreskin CD3+CD4+CCR5+ cell density is correlated with soluble
inflammatory mediator levels in the coronal sulcus. Foreskin tissue collected from the
randomized controlled trial were cryosectioned at 8µm and stained for CD3, CD4, CCR5,
and nuclei for immunofluorescent microscopy analysis. Tiled full tissue sections scans
were captured at 200x total magnification and a deep-learning cell segmentation
algorithm was used to quantify CD3+CD4+CCR5+ cells within 300µm of the apical
surface of the epidermis in each image. Soluble inflammatory mediator levels in coronal
sulcus swabs collected immediately before circumcision were measured using a
chemiluminescent multiplex ELISA assay. Levels of soluble E-Cadherin, IL-1β, IL-8 and
Resistin were positively correlated with CD3+CD4+CCR5+ cell density (p<0.05). Trend
lines represent simple linear regressions. Significant correlations are indicated by red
trendlines and red p-values (p<0.05).
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Figure 16: Inner foreskin CD3-CD4+CCR5+ cell density is correlated with soluble
inflammatory mediator levels in the coronal sulcus. Foreskin tissue collected from the
randomized controlled trial were cryosectioned at 8µm and stained for CD3, CD4, CCR5,
and nuclei for immunofluorescent microscopy analysis. Tiled full tissue sections scans
were captured at 200x total magnification and a deep-learning cell segmentation
algorithm was used to quantify CD3-CD4+CCR5+ cells within 300µm of the apical
surface of the epidermis in each image. Soluble inflammatory mediator levels in coronal
sulcus swabs collected immediately before circumcision were measured using a
chemiluminescent multiplex ELISA assay. Levels of soluble E-Cadherin, IL-1β, IL-8 and
Resistin were positively correlated with CD3-CD4+CCR5+ cell density (p<0.05). Trend
lines represent simple linear regressions. Significant correlations are indicated by red
trendlines and red p-values (p<0.05).
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Figure 17: Percent coverage of inner foreskin CD4+CCR5+ tissue area is not
correlated with soluble inflammatory mediator levels in the coronal sulcus. Foreskin
tissue collected from the randomized controlled trial were cryosectioned at 8µm and
stained for CD3, CD4, CCR5, and nuclei for immunofluorescent microscopy analysis.
Tiled full tissue sections scans were captured at 200x total magnification and an
automated pixel-based algorithm was used to quantify the CD4+CCR5+ tissue area
within 300µm of the apical surface of the epidermis in each image. Soluble inflammatory
mediator levels in coronal sulcus swabs collected immediately before circumcision were
measured using a chemiluminescent multiplex ELISA assay. Abundance of all soluble
inflammatory molecules measured were not correlated with CD4+CCR5+ tissue area
(p>0.05). Trend lines represent simple linear regressions. The p-value and R2 value for
the simple linear regressions are provided with each scatter plot.
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4.3.5

High absolute abundance of BASIC species, but not overall
bacterial load, is associated with HIV target cell density
Previous studies by our group have found BASIC species, but not overall

bacterial load, to be associated with HIV seroconversion, increased penile abundance of
inflammatory cytokines/chemokines, and increased abundance of CD4+ T cells in the
foreskin (75). In unpublished analysis of the coronal sulcus swab samples from the RCT
by our collaborators, it was found that the penile abundance of BASIC species was
associated with penile soluble inflammatory marker abundance. Our analysis in section
4.3.4 of this thesis has also found that the abundance of penile soluble inflammatory
markers was also associated with HIV target cell availability in the inner foreskin
(Figures 14-17). Given these observations and results supporting that penile bacterial
abundance, penile inflammatory marker abundance, and foreskin HIV target cell
abundance are all reduced by antimicrobial treatments, we sought to determine if the
difference in foreskin HIV target cell density between study participants could be
explained by the difference in abundance of BASIC species (Figure 18-19).
We classified men from the randomized controlled trial into 4 groups: High
BASIC (group 1, n = 28), Medium BASIC (group 2, n = 52), No BASIC (group 3, n =
35), and High Control (group 4, n = 28). Groups 1 to 3 were determined by sorting all
participants based on the pooled absolute abundance (log10 16S RNA gene copies per
swab) of BASIC species (median: 4.16438, IQR: 0, 5.14056) in coronal sulcus swabs
collected at time of circumcision. Men in the top quartile for BASIC species absolute
abundance were placed in the High BASIC species group (BASIC absolute abundance ≥
5.14056, n = 28). Men with no detectable BASIC bacteria were placed in the No BASIC
group (BASIC absolute abundance = 0, n = 35). Remaining men were placed in the
Medium BASIC group (0 < BASIC absolute abundance < 5.14056, n = 52). Group 4
(High Control) was determined by sorting all participants based on pooled absolute
abundance (log10 16S RNA gene copies per swab) of control taxa bacteria (median:
4.75902, IQR: 4.05717, 5.39375) and then selecting the men in the top quartile for
control taxa absolute abundance (control taxa absolute abundance > 5.39375, n = 28).

84

Total bacterial density of the High BASIC group and High Control group were
not significantly different from each other; however, the absolute abundance of BASIC
species was significantly higher in the High BASIC group when compared to the High
Control group (Figure 18). Overall, we found that the abundance of BASIC bacteria was
associated with the abundance of HIV target cell density (Figure 18). However, this
relationship was only seen in the inner foreskin. The density of HIV target cells and the
percent coverage of CD4+CCR5+ tissue area were similarly low in all 4 groups in the
outer foreskin and matched the inner foreskin HIV target cell density and percent
coverage of CD4+CCR5+ tissue area for the No BASIC group. Men in the High BASIC
group had significantly higher CD3+ cell density, CD3+CD4+CCR5+ cell density, CD3CD4+CCR5+ cell density, and percent coverage of CD4+CCR5+ tissue area compared to
the No BASIC group (p<0.05) (Figure 19A-D). Furthermore, similar to previous
findings we also found that the relative proportions of specific T cell subsets were similar
across all 4 groups in the inner foreskin. This suggests that BASIC bacteria were not
inducing the recruitment of specific T cell subsets more than others. Rather, it seems that
all T cells were recruited to the inner foreskin by BASIC bacteria in a generalized manner
(Figure 19E).
Interestingly, inner foreskin CD3+ cell density (No BASIC median: 1.14 x 10-4
cells/µm2, High Control median: 1.19 x 10-4 cells/µm2), CD3+CD4+CCR5+ cell density
(No BASIC median: 3.83 x 10-5 cells/µm2, High Control median: 3.72 x 10-5 cells/µm2),
CD3-CD4+CCR5+ cell density (No BASIC median: 1.37 x 10-4 cells/µm2, High Control
median: 1.33 x 10-4 cells/µm2), and the percent coverage of CD4+CCR5+ tissue area (No
BASIC median: 0.2493%, High Control median: 0.2925%) were very similar between the
No BASIC group and High Control group. In fact, inner foreskin CD3+CD4+CCR5+ cell
density, CD3-CD4+CCR5+ cell density, and percent coverage of CD4+CCR5+ tissue
area were all significantly higher in the High BASIC group when compared to the High
Control group (Figure 19A-D). Taken together, these results further support the idea that
the abundance of BASIC bacteria rather than total bacteria density is associated with HIV
target cell recruitment in the inner foreskin
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Figure 18: Men in the top quartile for abundance of BASIC species and men in the
top quartile for abundance of control taxa have similar total bacterial abundance
but differ in abundance for BASIC species. Men from the randomized controlled trial
were sorted based on pooled absolute abundance of BASIC species then sorted based on
pooled control taxa absolute abundance in coronal sulcus swabs collected at time of
circumcision. Men in the top quartile for BASIC abundance were placed in the High
BASIC group (n = 28), men with no detectable BASIC bacteria were place in the No
BASIC group (n = 35), and men with detectable BASIC bacteria but were not in the top
quartile for BASIC abundance were placed in the medium BASIC group (n = 52). Men in
the top quartile for control taxa abundance were placed in the High BASIC group. The
total bacterial abundance (A) of High BASIC group men and High Control group men
were not significantly different. However, BASIC species absolute abundance (B) was
significantly higher in the High BASIC group men compared to the High Control group
men. Differences in bacterial abundance was assessed using a Kruskal-Wallis test with a
Dunn’s multiple comparisons test. Significant differences (p≤0.05) are represented by
asterisks (***p≤0.001, ****p≤0.0001).
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Figure 19: High abundance of BASIC species is associated with recruitment of HIV
target cells to the inner foreskin without alterations in T cell subset distribution.
Participants in the randomized controlled trial were sorted into 4 groups based on BASIC
species abundance and control taxa abundance: High BASIC group (n = 28), Medium
BASIC group (n = 52), No BASIC group (n = 35), and High Control group (n=28). The
(A) CD3+ cell density, (B) CD3+CD4+CCR5+ cell density, (C) CD3-CD4+CCR5+ cell
density, and (D) percent coverage of CD4+CCR5+ tissue area in the inner and outer
foreskin of men in each of the groups was determined through immunofluorescent
microscopy and automated image analysis. Measurement of cell density and
CD4+CCR5+ tissue was restricted to the area within 300µm of the apical surface of the
epithelium. Lines and boxes in scatter plots (A-D) represent median and interquartile
range respectively. (E) Proportions of T cell subsets in each of the groups in the inner
foreskin. Differences in cell density or percent coverage of CD4+CCR5+ tissue area was
determine using a Kruskal-Wallis test followed by a Dunn’s multiple comparisons test.
Significant differences (p≤0.05) are represented by asterisks (*p≤0.05, **p≤0.01,
****p≤0.0001).
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4.4 Discussion
Safe penile circumcision can reduce HIV susceptibility by up to 60% in men,
however, many at risk men still choose to undergo this procedure and the mechanism
behind how circumcision is protective against HIV infection is not fully understood (14–
16,18). Previous studies have shown that specific species of penile anaerobic bacteria
may be associated with local inflammation that leads to the recruitment of HIV
susceptible immune cells in the penis (64,73,75). Thus, one way that circumcision could
reduce HIV susceptibility in men is by increasing air exposure on the penis which
eliminates these high-risk bacteria. If the abundance of penile anaerobes is indeed a
determinant of HIV susceptibility, then targeted reduction of these bacteria using
antimicrobials could potentially be a novel low-cost method for reducing HIV risk for
men who choose to remain uncircumcised. However, it is still unclear if it would be
possible to modify the penile microbiome using antimicrobials and how this would
influence the availability of HIV target cells in the penis.
In this chapter we described the results of a randomized controlled trial looking at
effect of antimicrobials on penile bacteria, inflammation, and HIV susceptibility in the
foreskin (77). We provide evidence that antimicrobials can decrease the abundance of
HIV target cells in the inner foreskin and provide evidence that supports the hypothesis
that there is a causal effect between abundance of anaerobic species and HIV
susceptibility (Figures 12, 18, 19). We found that the abundance of BASIC species rather
than total bacterial density was correlated to abundance of HIV target cells in the inner
foreskin (Figures 18-19). Additionally, the abundance of soluble inflammatory mediators
at time of circumcision was also correlated with HIV target cell density in the inner
foreskin (Figures 14-17).
Among the treatments examined in the randomized controlled trial, clindamycin
and metronidazole appears to have the most potential as a microbiome-targeted
intervention that can be used to reduce HIV susceptibility. Unpublished analysis by our
collaborators have shown that these 2 treatments were able to reduce the abundance of
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BASIC bacteria and soluble inflammatory molecules in the coronal sulcus. We have also
showed in this thesis that HIV target cell availability is lower in the foreskin of men in
the topical clindamycin and topical metronidazole groups (Figure 12). It is unsurprising
that these treatments would have such a dramatic effect on the abundance of BASIC
bacteria since these treatments are commonly used for the treatment of BV (76,77).
BASIC species such as Prevotella bivia are commonly found in microbiome of women
with BV. However, it is interesting that the penile abundance of BASIC bacteria was only
significantly reduced by topical antimicrobials and that lower HIV target cell availability
was seen in the topical clindamycin and metronidazole group men within the short
duration of treatment application (4 weeks) (Figures 11-12). While we’ve seen that
proportions of T cells expressing CD4 and CCR5 were similar between different
treatment groups and BASIC bacteria recruited T cells in a generalized manner, future
work should be done to further characterize the phenotype of CD3+ cell subsets that were
reduced because of clearance of BASIC bacteria (Table 7 & Figure 19). It is possible
that the lower availability of CD3+ cell subsets in the topical clindamycin and
metronidazole group men can be explained by the reduction in the abundance resident
memory T cells (TRM). Resident memory T cells are a subset of memory T cells that
persist long term in peripheral tissues including skin and genital mucosal tissue and
respond rapidly to challenge by antigens (151–153). These cells are specific for
pathogens and commensals commonly encountered (Staphylococcus epidermidis, HSV1) at the site they reside in and accumulate in response to repeated antigen exposure. For
instance, in mouse models it was seen that dendritic cells in the skin were capable of
presenting antigen to local populations of HSV-specific TRM to generate a recall immune
response entirely contained within the skin (154–156). It is possible that topical
antimicrobials, which were the most effective at reducing the penile abundance of BASIC
bacteria in the trial, lowered the abundance of TRM by reducing the availability of
antigens that contributed to TRM proliferation. Previous studies have also shown that TRM
progenitor cells generated by recent skin infection migrated in the greatest number into
inflamed skin in an antigen independent manner (157). This supports the idea that the
abundance of BASIC bacteria in the sub-preputial space may cause the recruitment of
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HIV susceptible cells to the inner foreskin by inducing local inflammation. Consistent
with previous findings, based on the results from the RCT we also found that CD3+ cell
density, CD3+CD4+CCR5+ cell density, CD3-CD4+CCR5+ cell density, and percent
coverage of CD4+CCR5+ tissue area was higher in the inner foreskin when compared to
the outer foreskin (Figure 13).
In addition to CD3+ HIV target cells, the abundance CD3-CD4+CCR5+ cells in
the inner foreskin were also reduced by antimicrobial treatments and were correlated with
the penile abundance of BASIC species (Figures 12 & 19). Previous studies examining
the relationship between bacteria associated with high HIV-risk with immune cell density
in the foreskin have mostly focused on T lymphocytes (73,75). However, non CD3+ cells
that express CD4+ and CCR5+ such as Langerhans cells are the first cells to encounter
HIV virions that penetrate the foreskin in sexual transmission. While CD4+ T cells are
the main reservoirs for productive HIV infection, the abundance of non CD3+ cells also
play an important role in the spread the virus (29,39,97). Grouping of all CD3- HIV
target cells into the category of CD3-CD4+CCR5+ cells enabled us to gain a holistic
understanding of the total abundance of non CD3+ cells that HIV virions can bind to.
However, this grouping strategy also limits our understanding of the relationship between
penile bacteria and the availability of specific CD3- cell populations such as Langerhans
cells and dendritic cells in the context of HIV infection. Future work should elaborate on
the findings between CD3- HIV target cell density in the inner foreskin and the
abundance of BASIC bacteria in this thesis. This includes, but is not limited to,
characterization of the composition of specific CD3-CD4+CCR5+ cell subsets, as well
as, other innate immune cells that contribute to local inflammation in individuals with
high or low penile abundance of BASIC species. More downstream work could also
compare gene expression by HIV target cells between individuals with high or low
abundance of BASIC species. This information will provide a better understanding of the
immune profile and the mechanism by which HIV susceptible CD4+ T cells are recruited
in the foreskin of individuals who have a high penile abundance of BASIC species.
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In this thesis we have shown that men in the topical clindamycin, topical
metronidazole and oral tinidazole groups all had significantly lower CD3+CD4+CCR5+
cell density in the inner foreskin compared to men in the control group (Figure 12).
However, unpublished analysis completed by our collaborators have shown that only oral
tinidazole reduced the infection of inner foreskin derived CD4+ T cells with a HIV
pseudovirus in vitro. It appears that while reduction in the abundance of BASIC bacteria
on the penis influenced the generalized recruitment of HIV target cells into the inner
foreskin, the effect of oral tinidazole on in vitro viral entry could be mediated through a
mechanism unrelated to the abundance of BASIC bacteria. Oral tinidazole could be
modifying HIV susceptibility by directly affecting the cellular properties of HIV target
cells. While men in the oral tinidazole group had lower abundance of CD3+ cells and
CD3+CD4+CCR5+ cells in the inner foreskin when compared to control, oral tinidazole
treatment did not significantly reduce the abundance of BASIC species after 1 or 4 weeks
of treatment (Figures 11-12). Interestingly, in accordance with the in vitro viral entry
results seen with oral tinidazole completed by our collaborators, a previous study has
shown that oral metronidazole use significantly reduced ex-vivo HIV entry into cervical
CD4+ T cells (158). Nitroimidazole compounds, which includes both tinidazole and
metronidazole, function as antimicrobials through the disruption of nucleic acid synthesis
in microbial cells (159,160). Several studies have investigated the potential cytotoxic or
genotoxic properties that may affect human immune cells; however, these studies were
often contradictory and had mixed conclusions (161–165). It is possible that oral
metronidazole or tinidazole could be having a direct effect on proliferation or gene
expression in CD4+ T cells which influences its susceptibility to HIV infection, however,
more downstream studies are necessary to investigate if this is really the case. An
immediate next step to follow-up on the results of the current study and to assess if oral
tinidazole/metronidazole has a direct effect on CD4+ T cells could be to perform an
infection assay to directly assess how various concentrations of oral
metronidazole/tinidazole affects viral propagation of HIV in cultured CD4+ T cells.
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As one of the outcomes of the RCT, our collaborators measured the abundance of
9 soluble molecules to broadly determine if antimicrobials can decrease the abundance of
inflammatory markers and if the abundance of inflammatory markers are associated with
both the abundance of BASIC bacteria and HIV target cells in the foreskin. These 9
soluble markers were selected based on their high abundance in the sub preputial space in
healthy volunteers and because of their role in inflammation. Unpublished preliminary
results from our collaborators have shown that soluble inflammatory can be reduced by
antimicrobials and this reduction is associated with the reduction of penile bacteria. We
have also shown that soluble inflammatory molecule levels in coronal sulcus swabs
collected at time of circumcision is associated with HIV target cell density in the inner
foreskin. However, we recognize that far more soluble inflammatory molecules are likely
to be involved in facilitating the recruitment of HIV target cells into the inner foreskin.
Future work could expand on the current panel of soluble inflammatory markers to gain a
better understanding of the local inflammation associated with penile bacteria and how
this inflammation is related to immune cell composition in the penis. Furthermore, at the
time of writing this thesis, more penile microbiome analysis by our collaborators was still
being completed and analysis of the effect of antimicrobials on epithelial integrity was
still being completed by a member of our group. More sophisticated penile microbiome
analysis could enable a better understanding of how bacterial species other than the
BASIC species presented in this thesis and how co-association of bacteria influence HIV
susceptibility. Results on the impact of antimicrobial treatment on epithelial integrity
could also be paired with results from this thesis to investigate the relationship between
epithelial integrity and HIV target cell abundance.
As a proof-of-concept, the current results from the randomized controlled trial
have demonstrated that the penile microbiome can be altered using antimicrobials, and
the resulting change in the abundance of BASIC bacteria is associated with decreased
penile abundance of soluble inflammatory molecules and HIV target cells. However,
more work should be done to investigate how long the effect of antimicrobials on HIV
target cells can persist. It is very possible that both the abundance of BASIC species and
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HIV target cells would return to levels seen prior to the application of antimicrobial
treatment if treatment is discontinued. In the case of bacteria, it is well known that while
the dysbiosis seen in bacterial vaginosis in women can be treated using antimicrobials,
recurrence of bacterial vaginosis is very common (166,167). Based on unpublished
results from out collaborators, we have seen that the abundance of BASIC bacteria after 1
week and 4 weeks of treatment with topical antimicrobials were both significantly lower
than baseline. However, the abundance of BASIC bacteria after 1 week, which
corresponded to a more intensive treatment regimen, was lower than the abundance of
BASIC bacteria at time of circumcision. The abundance of BASIC bacteria on the penis
appears to have rebounded through the less intensive treatment course from after week 1
to time of circumcision (Figure 11). The recurrence of BASIC bacteria following
termination of treatment could be problematic for the feasibility of using antimicrobials
as a potential tool for HIV prevention. Specifically, if resident memory T cells are in fact
the main T cells reduced by decreased BASIC abundance. Based on previous studies, it is
seen that TRM tend to persist long-term in previous sites of inflammation. In the case of
HSV, TRM have been seen to persist in HSV ulcers even after viral clearance
(156,157,168–171). In inflammatory lesions, while the abundance of TRM can be reduced
with anti-inflammatory therapy, TRM abundance will return to previously observed levels
when treatment is discontinued (154). Like these observations, it is possible that the
abundance of HIV target cells in the foreskin will return to previously levels when
antimicrobial treatment is discontinued. Future work should examine how long the effect
of antimicrobial treatments on the penile microbiome and HIV target cells can be
sustained after treatment to determine if antimicrobials can feasibly be used as a tool for
HIV prevention.
In conclusion, the results presented in this chapter have shown that antimicrobials
can reduce the penile abundance of HIV target cells. We have also provided evidence
supporting the idea that there is a causal relationship between the abundance of bacteria
previously associated with HIV risk and HIV susceptibility. We have shown that the
abundance of bacteria associated with HIV risk and the penile levels of soluble
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inflammatory molecules are associated with the abundance of HIV susceptible cells in the
inner foreskin. The ability of antimicrobials to influence inflammation and HIV target
cell density in the penis suggest that microbiome-based interventions could be a new
possible strategy for HIV preventions.
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Chapter 5

5

Overall Summary and Future Directions
In this thesis, I described select results from a randomized controlled trial looking

at effect of antimicrobials on penile bacteria, inflammation, and HIV susceptibility in the
Ugandan men. Specifically, this thesis focused on using IF microscopy analysis to
measure the availability of HIV target cells in the foreskin tissue of participants enrolled
in the RCT. To measure HIV target cell availability in the large number of foreskin
sample images from the RCT in an automated fashion, I developed and validated a deep
learning cell segmentation model that can quantify HIV target cells in foreskin tissue
based on staining for CD3, CD4, CCR5, and nuclei. The performance of this model was
comparable to manual counting and exceeded the performance of a conventional
automated cell segmentation algorithm that uses image thresholding to quantify cells.
Using the deep-learning model and a previously validated automated analysis algorithm
that measured the tissue area susceptible to HIV entry (tissue area positive for CD4 and
CCR5), we found that HIV target cell availability in the inner foreskin of men was
significantly lower in the topical clindamycin, topical metronidazole, and oral tinidazole
groups when compared to the control group. The effect of antimicrobials on HIV target
cell abundance in the foreskin was limited to the inner foreskin and unpublished analysis
of penile microbiome and soluble inflammatory molecule data from the RCT by our
collaborators showed that topical antimicrobial treatments reduced the penile abundance
of BASIC species bacteria and soluble inflammatory molecule levels. Furthermore, I
found that the availability of HIV target cells in the inner foreskin was correlated to the
penile abundance of soluble inflammatory molecules and BASIC species bacteria. These
results support the hypothesis that antimicrobials can decrease the penile abundance of
BASIC species, which is associated with the reduction in penile inflammation and HIV
target cell availability in the foreskin. The results of this thesis have also shown as a
proof-of-concept that microbiome-based interventions can be used to reduce HIV
susceptibility in men. Overall, these results can contribute to development of new HIV
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prevention strategies, which can be particularly useful to protect men who choose to
remain uncircumcised.
To my knowledge, the deep-learning model described in chapter 3 of this thesis is
the first report of any kind to use deep learning to quantify HIV target cell availability in
genital mucosal tissue. The development of this model opens opportunities for future
studies in our group and this work can be easily adapted by other groups who are looking
for methods to accurately quantify immune cells in IF images of mucosal tissue. The
trained deep learning model, the framework to train new deep learning models, and the
annotated training data set used in this thesis are all available on public domains.
The trained model used in this study can be used without modification by our
group or other investigators to quantify HIV target cells in foreskin tissues. The
availability of this model is particularly useful for clinical studies investigating HIV
susceptibility in men as large sample sets can be quickly analyzed in an objective
manner. New deep learning models to identify other types of immune cells in mucosal
tissues can be easily trained using our training framework. For example, the training
framework described in chapter 3 is currently being used by students in our group to train
new models to identify neutrophils, dendritic cells, and macrophages in the foreskin
tissue of pediatric patients with phimosis. Additionally, previous studies have shown that
the abundance of BASIC species are associated with the abundance of CD4+ T cells in
the foreskin but results in this thesis have shown that both CD3+ HIV target cells and
CD3- HIV target cells are associated with BASIC species abundance. In future work
elaborating on the results of this thesis, new deep learning models can be trained to
quantify other types of immune cells that are CD3- (for example Langerhans cells,
macrophages etc.) to further characterized the exact subsets of CD3- immune cells that
are associated with BASIC species abundance in the RCT samples. Manual annotation of
training datasets is by far the most time-consuming step in the training of deep-learning
algorithms. Open-access of the training dataset in this thesis can greatly speed up the
development new deep-learning algorithms that utilize different techniques for HIV
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target cell quantification since training images are very generalizable. Our deep-learning
model currently only enables the quantification of HIV target cells, however, another
aspect of HIV target cell availability that could be relevant for HIV susceptibility is the
spatial distribution of target cells. Specifically, HIV target cells being closer to the
surface of the epidermis would mean that they would be easier for virions to access.
Improvements on the deep learning model used in this thesis could focus on measuring
the distance of HIV target cells to the apical or basal edge of the epidermis.
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